uracil has been researched along with Cancer of Liver in 307 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 61 (19.87) | 18.7374 |
| 1990's | 63 (20.52) | 18.2507 |
| 2000's | 117 (38.11) | 29.6817 |
| 2010's | 58 (18.89) | 24.3611 |
| 2020's | 8 (2.61) | 2.80 |
| Authors | Studies |
|---|---|
| Basto, R; Bonito, N; Gomes, I; Jacinto, P; Magalhães, J; Paulo, J; Pereira, TC; Sousa, G; Sousa, MJ | 1 |
| Ding, X; Liu, Y; Lo, WS; Ng, KK; Wan, HL; Wong, AM; Wong, N; Xu, M; You, W | 1 |
| Atreya, CE; Carnevale, J; Cinar, P; Fidelman, N; Griffith, M; Milloy, MA; Van Loon, K; Venook, AP | 1 |
| Aguilar, H; Asatryan, A; Bondin, M; Cacoub, P; Carvalho, A; Castro, RE; Charafeddine, M; Cohen, DE; Dieterich, D; Felizarta, F; Hu, YB; Khan, N; Marinho, RT; Poordad, F; Siddique, A | 1 |
| Hosono, M; Ienaga, T; Iwabuchi, S; Kawasaki, K; Okazaki, T; Owada, Y; Tanaka, S | 1 |
| Filipič, M; Hercog, K; Štampar, M; Štern, A; Žegura, B | 1 |
| Endo, Y; Hirashita, T; Inomata, M; Itoh, H; Iwao, M; Iwashita, Y; Masuda, T; Shiraiwa, K; Suzuki, Y; Tada, K; Tanaka, R; Uchida, H | 1 |
| Abd Elmaaboud, MA; Arab, HH; Kabel, AM | 1 |
| Barzi, A; Berger, MD; Cao, S; Gopez, R; Lenz, HJ; Loupakis, F; Marmorino, F; Mennitto, A; Miyamoto, Y; Murgioni, S; Ning, Y; Okazaki, S; Rossini, D; Schirripa, M; Suenaga, M; Yamaguchi, T; Yang, D; Zhang, W | 1 |
| Fujiya, M; Hasebe, T; Honda, S; Nakajima, S; Okumura, T; Sawada, K | 1 |
| Baba, E; Denda, T; Enomoto, M; Esaki, T; Fukuoka, S; Gosho, M; Ishikawa, T; Kajiwara, T; Kashiwada, T; Komatsu, Y; Kumekawa, Y; Makiyama, C; Moriwaki, T; Okuyama, H; Sakai, D; Satake, H; Shimada, Y; Sugimoto, N; Sugiyama, M; Suto, T; Takashima, A; Tamura, T; Taniguchi, H; Watanabe, T; Yamashita, K; Yamazaki, K | 1 |
| Rostkowska, K; Simon, K; Szymanek-Pasternak, A | 1 |
| Cameán, AM; Filipič, M; Hercog, K; Jos, Á; Maisanaba, S; Žegura, B | 1 |
| Beijnen, JH; de Vries, N; Deenen, MJ; Jacobs, BAW; Koopman, M; Rosing, H; Samim, M; Schellens, JHM; Snoeren, N; van Hillegersberg, R | 1 |
| Arakawa, S; Asano, Y; Horiguchi, A; Imaeda, Y; Isetani, M; Ishihara, S; Ito, M; Ito, R; Kamio, K; Kawabe, N; Kawai, T; Nagata, H; Shimizu, K; Tomishige, H; Yasuoka, H | 1 |
| Berak, H; Białkowska, J; Bolewska, B; Fleischer-Stępniewska, K; Flisiak, R; Garlicki, A; Janczewska, E; Karpińska, E; Karwowska, K; Nazzal, K; Piekarska, A; Simon, K; Tomasiewicz, K; Tronina, O; Tuchendler, E; Zarębska-Michaluk, D; Łucejko, M | 1 |
| Giménez-Manzorro, A; Herranz-Alonso, A; Matilla-Peña, A; Revuelta-Herrero, JL; Sanjurjo-Sáez, M | 1 |
| Bianconi, D; Drimmel, M; Gleiss, A; Kieler, M; Prager, GW; Scheithauer, W; Siebenhüner, A; Unseld, M; Winder, T | 1 |
| Baba, E; Denda, T; Esaki, T; Fukuoka, S; Ishikawa, T; Ito, M; Kajiwara, T; Kashiwada, T; Katsumata, K; Kishimoto, J; Komatsu, Y; Kumekawa, Y; Makiyama, A; Moriwaki, T; Oki, E; Okuyama, H; Sakai, D; Satake, H; Shimada, Y; Sugimoto, N; Suto, T; Takashima, A; Tamura, T; Taniguchi, H; Tsuchihashi, K; Ueno, H; Yamashita, K; Yamazaki, K | 1 |
| Baba, H; Denda, T; Esaki, T; Fujii, H; Goto, M; Hamamoto, Y; Komatsu, Y; Moriwaki, T; Muro, K; Nakayama, N; Nishina, T; Ohtsu, A; Shimada, Y; Shinozaki, E; Sugimoto, N; Takayama, T; Tanase, T; Tsuji, A; Tsuji, Y; Yamaguchi, K; Yamazaki, K; Yoshino, T | 1 |
| Barzi, A; Cho, SK; Hay, JW | 1 |
| Hiramatsu, M; Imai, Y; Kobayashi, T; Kono, E; Sakane, J; Suzuki, Y; Tsunematsu, I | 1 |
| Baba, H; Beppu, T; Chikamoto, A; Fukubayashi, K; Hayashi, H; Imai, K; Imamura, YU; Ishiko, T; Miyata, T; Yamashita, YI | 1 |
| Baicus, C; Constantinescu, I; Diculescu, M; Dumitru, R; Gavrila, D; Istratescu, D; Manuc, M; Manuc, T; Oproiu, A; Preda, CM; Sandra, I; Tieranu, C; Vasilescu, C; Voiosu, T | 1 |
| Akizuki, S; Fushiya, N; Nishino, H; Ohnishi, A; Takagi, I | 1 |
| Huang, FZ; Jiang, XZ; Liu, XY; Nie, WP; Wang, CF; Wang, YQ | 1 |
| Chen, YM; Chiang, EP; Lin, WL; Lin, YJ; Tang, FY; Wang, YC | 1 |
| Hatano, E; Koyama, Y; Takada, Y; Tanabe, K; Taura, K; Uemoto, S | 1 |
| Chen, HC; Chen, HH; Chen, WT; Chien, CR; Hsiao, CF; Lee, HH; Lin, TC; Lin, TY; Liu, TW; Wang, LW | 1 |
| Hasegawa, K; Ijichi, M; Kawasaki, S; Kokudo, N; Koyama, H; Makuuchi, M; Miyagawa, S; Oba, M; Saiura, A; Takayama, T; Teruya, M; Yamamoto, J; Yoshimi, F | 1 |
| Andreone, P; Gamal, N; Vitale, G | 1 |
| Halász, T; Horváth, G; Hunyady, B; Makara, M | 1 |
| Ishizuka, M; Iso, Y; Kato, M; Kubota, K; Nemoto, T; Shimoda, M; Tago, K | 1 |
| Antonov, K; Atanasova, E; Boyanova, Y; Jelev, D; Krastev, Z; Mateva, L; Petkova, T; Tomov, B; Zheleva, N | 1 |
| Johnson, S; Marx, SE; Misurski, D; Parisé, H; Saab, S; Sanchez Gonzalez, Y; Virabhak, S; Wang, A | 1 |
| Gonzalez, YS; Johnson, S; Juday, T; Misurski, D; Parisé, H; Saab, S; Virabhak, S; Wang, A | 1 |
| Hasegawa, K; Ijichi, M; Kawasaki, S; Kokudo, N; Koyama, H; Makuuchi, M; Matsuyama, Y; Miyagawa, S; Mizunuma, N; Oba, M; Saiura, A; Takahashi, M; Takayama, T; Teruya, M; Watanabe, T; Yamamoto, J; Yoshimi, F | 1 |
| Hasegawa, J; Hirota, M; Kameda, C; Kawabata, R; Koga, C; Matsumura, T; Matsunami, N; Morishima, H; Murakami, M; Noura, S; Oda, N; Shimizu, J; Takata, A; Yasuyama, A | 1 |
| Albillos, A; Ampuero, J; Arenas, J; Bañares, R; Calleja, JL; Crespo, J; Diago, M; Fernandez, I; García-Eliz, M; García-Samaniego, J; Gea, F; Jorquera, F; Lens, S; Llaneras, J; Llerena, S; Mariño, Z; Morillas, RM; Muñoz, R; Navascues, CA; Pascasio, JM; Perelló, C; Rincón, D; Rodriguez, CF; Ruiz-Antorán, B; Sacristán, B; Serra, MA; Simon, MA; Torras, X; Turnes, J | 1 |
| Nakano, T; Tomimatsu, H | 1 |
| Ashikawa, K; Ishii, T; Komoriyama, H; Mikami, S; Ohtsubo, T | 1 |
| Aoki, K; Hoshikawa, K; Nitta, H; Noda, H; Oyama, K; Wakabayashi, G | 1 |
| Ariche, A; Baruch, NB; Brenner, B; Dinerman, M; Greif, F; Idelevich, E; Kashtan, H; Mavor, E; Miller, R; Shani, A; Susmalian, S | 1 |
| Ikeda, M; Ito, M; Nanami, T; Ohashi, Y; Oshima, Y; Saito, F; Takeyama, T; Watanabe, M; Yajima, S; Yamazaki, K | 1 |
| Miki, H; Nakahira, S; Nakata, K; Okada, K; Okamura, S; Sugimoto, K; Suzuki, R; Tamura, S; Uji, K; Yoshida, A; Yoshimura, M | 1 |
| Fujiwara, H; Ichikawa, D; Ikoma, H; Kikuchi, S; Kokuba, Y; Kubota, T; Nakanishi, M; Ochiai, T; Okamoto, K; Okamura, H; Otsuji, E; Sakakura, C; Sonoyama, T; Taniguchi, H | 1 |
| Asakawa, M; Fujii, H; Kono, H; Matsuda, M; Shiba, S | 1 |
| Saito, T; Sasaki, H; Tokunaga, Y | 1 |
| Iwanaga, T; Iwasaki, Y; Matsumoto, H; Nakano, D; Ohashi, M; Suzuki, Y; Takahashi, K; Yamaguchi, T | 1 |
| Akagi, K; Dono, K; Fujita, J; Hata, T; Hayashi, S; Ikeda, K; Kagawa, Y; Kawanishi, K; Kitada, M; Munakata, K; Shimano, T; Shimizu, J; Takamoto, K; Watanabe, N; Yasumoto, T; Zenitani, M | 1 |
| Higuchi, K; Ishikawa, T; Kamimura, T; Kubota, T; Ohta, H; Seki, K; Yoshida, T | 1 |
| Hida, J; Kitaguchi, H; Nakai, T; Okuno, K; Tokoro, T; Ueda, K; Yoshifuji, T | 1 |
| Hirata, K; Nakamura, Y; Takashima, T; Tayama, Y | 1 |
| Chen, PJ; Cheng, AL; Ding, YH; Hsu, C; Hsu, CH; Lin, ZZ; Shao, YY; Shen, YC | 1 |
| Aizawa, N; Enomoto, H; Hirota, S; Iijima, H; Ikeda, N; Imanishi, H; Ishii, A; Iwai, T; Iwata, Y; Nishiguchi, S; Saito, M; Sakai, Y; Shimomura, S; Takashima, T; Tanaka, H; Yamamoto, T; Yoh, K; Yoshikawa, S | 1 |
| Matsumoto, H; Mori, T; Takahashi, K; Yamaguchi, T; Yasutome, M | 1 |
| Adachi, K; Hiramatsu, S; Kurai, O; Miyano, M; Oka, H; Sasaki, E; Yamasaki, T | 1 |
| Boisdron-Celle, M; Cauchin, E; Galmiche, JP; Gamelin, E; Matysiak-Budnik, T; Morel, A; Mounier-Boutoille, H | 1 |
| Bando, M; Hattori, S; Ishita, T; Kubo, Y; Kumazawa, S; Kurata, N; Machinami, R; Matsumoto, K; Mori, M; Murata, Y; Nakamura, S; Oikawa, Y; Sato, Y; Tamura, N; Yagi, K | 1 |
| Furuse, J; Ikeda, M; Ishii, H; Mitsunaga, S; Morizane, C; Nakachi, K; Okusaka, T; Suzuki, E; Ueno, H | 1 |
| Doki, Y; Hirose, H; Ikeda, M; Kim, HM; Miyoshi, N; Mizushima, T; Mori, M; Okano, M; Sekimoto, M; Takemasa, I; Yamamoto, H; Yamashita, S | 1 |
| Ide, Y; Murata, K; Nishigaki, T | 1 |
| Chen, BB; Cheng, AL; Hsu, C; Hsu, CH; Hsu, CY; Hu, FC; Shen, YC; Shih, TT; Wei, SY; Yu, CW | 1 |
| Chang, AY; de Lima Lopes, G; Dicksey, JS; Palalay, M; Peters, WP | 1 |
| Doi, F; Ishikawa, N; Kohro, T; Kusumoto, C; Kusumoto, M; Matsumoto, T; Toyoda, S | 1 |
| Arai, Y; Ito, A; Kuwahara, M; Nakano, O; Satoh, M | 1 |
| Aoki, T; Endo, M; Tsuchida, A | 1 |
| Hara, Y; Kawano, T; Minami, Y; Tominaga, T; Ueda, S | 1 |
| Amano, K; Aratake, K; Hashimoto, T; Hirosawa, T; Itabashi, M; Kameoka, S; Narita, T; Ogawa, S; Seshimo, A | 1 |
| Fujii, M; Honda, S; Kuroda, H; Murayama, R; Nagata, N; Sakamoto, Y; Sako, T; Sanefuji, H; Sawatsubashi, T; Shinohara, I | 1 |
| Mikami, K; Murata, K; Nishigaki, T | 1 |
| Fukui, Y; Hamada, M; Horimi, T; Nakamura, T; Nishioka, Y; Ozaki, K; Shibuya, Y; Shima, Y; Teraishi, F; Uchida, Y | 1 |
| Bando, H; Inaki, N; Ishiyama, Y; Kaneko, M; Kotake, M; Kurokawa, M; Matsunaga, M; Yamada, T; Yamamoto, D; Yamamoto, M | 1 |
| Chamorey, E; Dahan, L; Evesque, L; Follana, P; Francois, E; Mari, V; Michel, C; Perrier, H; Seitz, JF; Smith, D | 1 |
| Goto, H; Hashizume, K; Ito, T; Kanazawa, H; Katada, N; Katano, Y; Morita, K; Narita, M; Nishimura, D; Okubo, K; Shibahara, H; Shimizu, J; Shiomi, M; Takeuchi, A; Takeyama, T | 1 |
| Aruga, A; Inoue, Y; Kotera, Y; Matsushita, N; Takeda, K; Yamamoto, M | 1 |
| Ayabe, H; Fukuoka, H; Hidaka, S; Nakagoe, T; Nanashima, A; Sawai, T; Shibasaki, S; Tanaka, K; Tsuji, T; Yamaguchi, H; Yamashita, H; Yasutake, T | 1 |
| Chiba, M; Hayashi, K; Inaba, Y; Kamio, Y; Koyama, M; Ohe, S; Watabe, S | 1 |
| Fishman, AD; Wadler, S | 1 |
| Benson, AB; Catalano, P; Cornfeld, MJ; Graham, DL; Huang, J; Marsh, JC; O'Dwyer, PJ | 1 |
| Baba, Y; Imamura, Y; Kubozono, O; Maenohara, S; Moriya, H; Ogura, Y; Tahara, K | 1 |
| Hatada, T; Inoue, Y; Kobayashi, M; Kusunoki, M; Miki, C; Ojima, E | 1 |
| Asaoka, T; Imasato, M; Iwazawa, T; Kanoh, T; Kinuta, M; Matsui, S; Monden, T; Nakano, Y; Okada, K; Okamura, J; Tono, T; Yano, H | 1 |
| Ebuchi, M; Hasegawa, K; Maruyama, M; Nagahama, T; Natui, S; Ochiai, T; Takashima, I | 1 |
| Hashimoto, D; Hoshino, T; Inokuma, S; Ishida, H; Ishizuka, N; Matsumoto, Y; Miura, T; Murata, N; Nakada, H; Odaka, A; Ohsawa, T; Suzuki, T; Takeuchi, I; Yamada, H; Yokoyama, M | 1 |
| Ito, T; Kamachi, H; Kamiyama, T; Kondo, M; Kurauchi, N; Matsushita, M; Nakagawa, T; Nishikawa, M; Ogata, T; Todo, S | 1 |
| Glimelius, B | 1 |
| Goda, F; Hagiike, M; Ishimura, K; Izuishi, K; Karasawa, Y; Maeta, H; Okano, K; Usuki, H; Yachida, S | 1 |
| Abe, K; Fujiwara, H; Gotoh, M; Hoshino, Y; Irinoda, T; Kanzaki, N; Kogure, M; Nakaya, T; Nemoto, T; Ohtani, S; Oyama, K; Saito, K; Takagane, A; Terashima, M; Yonezawa, H | 1 |
| CANTAROW, A; PASCHKIS, KE; RUTMAN, RJ | 2 |
| DE VERDIER, CH; POTTER, VR | 1 |
| BAUER, JM; WU, C | 1 |
| FRITZSON, P | 1 |
| ROTH, JS; WHITCUTT, JM | 1 |
| BHARGAVA, PM; JACOB, ST | 1 |
| MORSE, PA; POTTER, VR | 1 |
| Hanazaki, K; Kawasaki, S; Kobayashi, A; Matsushita, A; Misawa, R; Miwa, S; Miyagawa, S; Nakagawa, K; Nakata, T; Noike, T; Nomura, K | 1 |
| Futamura, N; Matsutomo, M; Sakamoto, K; Tateyama, K; Yasumura, M | 1 |
| Hashimoto, D; Hoshino, T; Inokuma, S; Ishida, H; Itoyama, S; Matsumoto, Y; Miura, T; Mori, T; Murata, N; Nakada, H; Odaka, A; Ohsawa, T; Okada, N; Shirakawa, K; Suzuki, T; Takeuchi, I; Yamada, H; Yokoyama, M | 1 |
| Ebuchi, M; Hasegawa, K; Kato, K; Maruyama, M; Nagahama, T; Shinoura, H; Takashima, I | 1 |
| Handa, R; Iijima, S; Kato, T; Kikkawa, N; Kurokawa, E; Naoi, Y; Oshima, S; Tsujie, M; Yamamoto, H | 1 |
| Arai, K; Iwasaki, Y; Katayanagi, S; Matsumoto, H; Miyamoto, H; Takahashi, K; Yamaguchi, T | 1 |
| Enomoto, M; Higuchi, T; Sugihara, K; Uetake, H | 1 |
| Imamura, M; Yamaki, T; Yasuda, M | 1 |
| Hirano, T; Kitahara, K; Magata, S; Matsuyama, S; Miyazaki, K; Mori, M; Shimonishi, T | 1 |
| CANTAROW, A; PASCHKIS, KE; STASNEY, J | 1 |
| Emura, T; Fukushima, M; Kitazato, K; Murakami, Y; Nakagawa, F | 1 |
| Aoki, T; Hayashida, Y; Kataba, Y; Kawakita, H; Kinoshita, M; Kubouchi, T; Saito, H; Sato, S; Takagi, M; Tamura, K; Tsuchida, A | 1 |
| Aihara, T; Fukuhara, A; Kouno, T; Murayama, M; Nakagawa, K; Nakamura, E; Niida, M; Nishimoto, Y; Nozaki, H; Syouda, S; Watanabe, Y; Yagyu, T; Yasuoka, H | 1 |
| Haga, S; Imamura, H; Kinoshita, J; Ogawa, K; Okabe, T; Shimizu, T; Watanabe, O | 1 |
| Fujihara, M; Fujita, M; Furukawa, Y; Hattori, Y; Ishii, Y; Kuniki, H; Matsumoto, N; Yajima, T; Yamamoto, M; Yamaoka, Y | 1 |
| Monden, M; Nagano, H; Sakon, M | 1 |
| Hashimoto, K; Higami, T; Itakura, M; Koike, M; Nio, Y; Yano, S | 1 |
| Arikawa, T; Horikoshi, I; Inagaki, H; Ito, N; Kotake, K; Kurokawa, T; Nagata, H; Nonami, T; Owa, Y; Suzumura, K; Tsubamoto, M | 1 |
| Endo, Y; Mai, M; Sasaki, T; Takahashi, Y; Yamashita, K | 1 |
| Baba, Y; Ishikawa, T; Kamimura, T; Mizuno, K; Oota, H; Watanabe, K; Yoshida, T | 1 |
| Fukunaga, H; Hata, T; Ikeda, M; Ikenaga, M; Monden, M; Ohue, M; Sekimoto, M; Seshimo, I; Takayama, O; Yamamoto, H; Yasui, M | 1 |
| Ebuchi, M; Hasegawa, K; Kato, K; Koide, A; Maruyama, M; Maruyama, S; Ohbu, M; Takashima, I | 1 |
| Ebisui, C; Fujimoto, T; Fukuchi, N; Hasuike, Y; Hayashi, N; Izawa, H; Izumiyama, K; Koshino, T; Sakita, I; Soma, I; Yoshida, T | 1 |
| Damdinsuren, B; Dono, K; Kondo, M; Marubashi, S; Miyamoto, A; Monden, M; Nagano, H; Nakamori, S; Nakamura, M; Ota, H; Sakon, M; Umeshita, K; Wada, H; Yamamoto, T; Yang, Y | 1 |
| Endo, Y; Fukushima, T; Kanazawa, M; Ohki, S; Ohshima, T; Saito, M; Sekikawa, K; Takenoshita, S | 1 |
| Hatakeyama, K; Muneoka, K; Shirai, Y; Wakai, T; Yokoyama, N | 1 |
| Arima, T; Horino, K; Inoue, M; Kaneda, H; Kimura, M; Kume, S; Matsushita, H; Morisaki, T; Nishimura, T; Uemura, K | 1 |
| Hirakawa, K; Ishikawa, T; Kato, Y; Nakata, B; Ogawa, Y; Onoda, N; Takagaki, K; Takashima, T | 1 |
| Hatakeyama, K; Muneoka, K; Okumura, S; Shirai, Y; Wakai, T; Yokoyama, N | 1 |
| Endo, S; Hashimoto, K; Higami, T; Itakura, M; Koike, M; Maruyama, R; Nio, Y; Tsuji, M; Yamaguchi, K; Yano, S | 1 |
| Fujii, H; Hasegawa, S; Hatano, E; Ikai, I; Kawashima, K; Matsumoto, S; Satoh, S; Shimahara, Y | 1 |
| Choi, CW; Choi, IK; Choi, JG; Kim, BS; Kim, JS; Kim, SJ; Kim, YH; Oh, SC; Park, KH; Seo, HY; Seo, JH; Shin, SW; Sul, HR; Sung, HJ; Yoon, SY | 1 |
| Ikeda, S; Ishibashi, N; Matono, K; Mizobe, T; Ogata, Y; Ogo, S; Ohkita, A; Ozasa, H; Sasatomi, T; Shirouzu, K | 1 |
| Hatakeyama, K; Kitami, CE; Koyama, Y; Kurosaki, I; Makino, H | 1 |
| Akasaka, Y; Hata, Y; Honda, S; Ito, T; Matsuoka, S; Nakajima, N; Ohmori, K; Sano, F; Yokoyama, R | 1 |
| Hamada, T; Ichimura, W; Minagawa, N; Mino, K; Naito, H; Orimo, T; Shibazaki, W; Shinohara, T | 1 |
| Fujii, Y; Kobayashi, T; Kuga, T; Matsuoka, T; Morikage, N; Nakayama, T | 1 |
| Aoki, F; Asai, K; Fujita, T; Hiyoshi, M; Masaki, Y; Nakamura, Y; Sugizaki, K; Tokuda, E | 1 |
| Fujimoto, T; Ishibashi, K; Ogawa, K; Umehara, A; Watanabe, K; Yokomizo, H; Yoshida, K; Yoshimatsu, K | 1 |
| Damdinsuren, B; Dono, K; Kato, H; Marubashi, S; Miyamoto, A; Monden, M; Nagano, H; Nakamura, M; Noda, T; Takeda, Y; Umeshita, K; Wada, H; Yoshioka, S | 1 |
| Doi, K; Furuhashi, S; Ishihara, A; Ishimoto, T; Kikuchi, N; Ogata, K; Ogawa, M; Ohchi, T | 1 |
| Ishigame, T; Ishii, Y; Okayama, H; Takahashi, M | 1 |
| Hatakeyama, K; Muneoka, K; Sakata, J; Shirai, Y; Wakai, T; Yokoyama, N | 1 |
| Morimoto, N; Shibaki, T | 1 |
| Kagaya, T; Kaneko, S; Kato, Y; Sunagozaka, H; Yamashita, T | 1 |
| Arai, K; Hashimoto, T; Hiruma, K; Iwasaki, Y; Matsumoto, H; Saze, Z; Takahashi, K; Yamaguchi, T; Yamashita, Y; Yasutome, M | 1 |
| Funakoshi, A; Furuse, J; Horikawa, Y; Ikeda, M; Ishii, H; Mizuno, N; Morizane, C; Nagase, M; Nakachi, K; Okusaka, T; Ueno, H; Yamao, K | 1 |
| Machida, H; Suzuki, K; Toda, H; Ushida, S | 1 |
| Hasegawa, K; Ijichi, M; Imamura, H; Kokudo, N; Makuuchi, M; Matsuyama, Y; Sano, K; Sugawara, Y; Takayama, T | 1 |
| Aikou, T; Haraguchi, Y; Ikeda, N; Kamikado, C; Sakamoto, F; Toyoyama, H; Ueno, S | 1 |
| Amano, M; Fujita, M; Hayashida, H; Higaki, N; Nakagawa, S; Niinobu, T; Nishikawa, Y; Sakon, M; Yamashita, S | 1 |
| Gega, M; Hashimoto, A; Ikeuchi, H; Kuno, T; Noda, M; Oshima, T; Tanaka, K; Tsukamoto, K; Yagyuu, T; Yamamura, T; Yanagi, H; Yoshikawa, R | 1 |
| Baruch, NB; Biran, H; Dinerman, M; Idelevich, E; Karminsky, N; Katsenelson, RL; Man, S; Shani, A; Zvi, NB | 1 |
| Aoki, T; Mino, A; Murahashi, K; Nishino, K; Sowa, M; Tachimori, A; Takagaki, K | 1 |
| Furukawa, T; Ishii, H; Maruyama, M; Ohata, M; Ohori, M; Saito, N; Sato, H; Tokura, Y | 1 |
| Imai, M; Ishikawa, T; Kamimura, H; Kamimura, T; Ohta, H; Seki, K; Togashi, T; Tsuchiya, A; Watanabe, K; Yoshida, T | 1 |
| Della Vigna, P; Di Meglio, G; Farris, A; Fazio, N; Goldhirsch, A; Lorizzo, K; Nolè, F | 1 |
| Hasegawa, H; Kanekiyo, S; Kubo, H; Tada, K; Watanabe, Y | 1 |
| Pinzello, G; Prisco, C; Zavaglia, C | 1 |
| Aoki, K; Hirama, K; Kazunori Ikenaga, S; Maruyama, M; Matsumoto, R; Oguro, H; Sakamoto, Y; Sakuraba, H | 1 |
| Amano, S; Aramaki, O; Kawasaki, A; Kuboi, Y; Mimatsu, K; Oida, T | 1 |
| Fukuchi, H; Ichinose, M; Kida, Y; Tanaka, H; Ueda, H | 1 |
| Ishikawa, T | 1 |
| Furue, H | 1 |
| Fujii, K; Hanaue, H; Kurosawa, T; Mitomi, T; Nakasaki, H; Tajima, T; Yasuda, S | 1 |
| Hiroshige, K; Ikeda, T; Korenaga, D; Nishizaki, T; Sugimachi, K; Takenaka, K; Yoshida, K | 1 |
| Arase, Y; Chayama, K; Ikeda, K; Koida, I; Kumada, H; Saitoh, S; Tsubota, A | 1 |
| Ikuta, H; Shibagaki, F; Tsuji, Y | 1 |
| Chao, C; Imada, T; Maehara, T; Matsumoto, A; Miyazaki, T; Morinaga, S; Takehana, T | 1 |
| Ban, K; Higashi, H; Ishihara, S; Kitazaki, M; Machida, T; Masuda, K; Matsumoto, M; Noma, M; Ota, M; Shida, H | 1 |
| Higaki, T; Ito, Y; Kono, S; Moriguchi, M; Nakata, Y; Oishi, H; Seki, N; Takahashi, T; Takano, S; Watanabe, Y | 1 |
| Furukawa, H; Hiratsuka, M; Imaoka, S; Ishikawa, O; Kabuto, T; Kameyama, M; Kishimoto, S; Nakano, H; Ohigashi, H; Sasaki, Y | 1 |
| Ishizawa, S; Masuyama, K; Oonishi, Y; Sawataishi, M; Suzuki, S; Wakaki, K; Yamazaki, K | 1 |
| Chin, K; Hattori, T; Hayakawa, M; Maeda, H; Morise, K; Morooka, Y; Saito, H; Sugihara, M | 1 |
| Fujiyama, S; Hashiguchi, O; Hayashida, T; Ikebe, M; Noumaru, S; Sato, K; Sato, T; Shibata, J | 1 |
| Dousei, T; Hashimoto, T; Moriguchi, S; Suhara, H; Taketani, S; Taniguchi, M; Ueda, H; Utsumi, T; Yamaguchi, T; Yoshikawa, K | 1 |
| Fukagawa, H; Hirohashi, Y; Iwanaga, A; Iyama, A; Kitahara, K; Miyazaki, K; Mori, M; Sasatomi, E; Tsutsumi, N; Yakushiji, H | 1 |
| Akimori, T; Izumiyama, F; Kamioka, N; Kawada, M; Kohara, H; Miyagawa, H; Nakatoh, H; Takahashi, T; Utsunomiya, T; Yuube, R | 1 |
| Ito, T; Koreeda, C; Naitoh, Y; Nakagawa, T; Okuno, H; Seki, T; Shiro, T; Tagawa, Y; Wakabayashi, M; Yamamura, H | 1 |
| Hino, F; Urabe, T | 1 |
| Itoh, Y; Ohkawa, S; Tamai, S; Tarao, K | 1 |
| Kosaki, G; Kurihara, M; Tominaga, T; Yoshida, Y | 1 |
| Itsubo, M | 1 |
| Kato, M; Kinoshita, K; Matsui, H; Miyazaki, I; Sawa, T; Takano, Y; Tomita, F; Yonemura, Y; Yoshimitsu, S | 1 |
| Iida, A; Ikeda, N; Komatsu, T; Ookubo, K | 1 |
| Inutsuka, K; Maruiwa, M; Noutomi, M; Ohta, J; Tokuhara, K | 1 |
| Fujita, M; Honda, I; Jingu, K; Satomi, D; Tsurumachi, T; Watanabe, K; Watanabe, S; Yamada, S; Yamamoto, H | 1 |
| Matsumoto, K; Onodera, H; Otawa, K; Sato, T; Ukai, K | 1 |
| Fujioka, S; Kato, K; Tomono, H | 1 |
| Hyakuna, Y; Kushibiki, K; Matsuoka, H; Shimada, M; Yokomichi, H | 1 |
| Fujii, M | 1 |
| Fujii, K; Fukuda, T; Hoshino, T; Ishii, T; Komatsu, M; Masamune, O; Mikami, K; Ohshima, S; Ono, T | 1 |
| Boku, N; Ishii, H; Kaneko, K; Kusada, O; Muro, K; Muto, M; Ohkuwa, M; Ohtsu, A; Sasaki, Y; Tajiri, H; Yoshida, S | 1 |
| Hirono, T; Hirosawa, H; Izumi, R; Kadoya, N; Konishi, I; Ohta, N; Saito, K; Ueda, N; Yoshimitsu, Y | 1 |
| Fukushima, M; Nakano, K; Saito, H; Satake, H; Takechi, T; Takeda, S; Uchida, J; Unemi, N | 1 |
| Haneda, T; Kamiyama, T; Nakanishi, K; Nishibe, M; Shimamura, T; Uchino, J; Une, Y | 1 |
| Mani, S | 1 |
| Ando, A; Asano, N; Bamba, T; Fujiyama, Y; Fukano, M; Inoue, T; Ito, A; Koyama, S; Kubo, M; Sasaki, M; Sato, J; Tsujikawa, T; Yoshioka, U | 1 |
| Fujiwara, Y; Hisa, N; Kume, M; Ogoshi, S; Tanaka, Y; Yoshida, S | 1 |
| Ando, E; Fukuda, H; Fukumori, K; Kato, O; Kusaba, T; Sata, M; Tanaka, M; Tanikawa, K; Yamamoto, H; Yamashita, F; Yano, Y | 1 |
| Kazumori, H; Moritani, M; Sizuku, T; Uchida, Y; Yamamoto, S | 1 |
| Chimori, Y; Ikoma, H; Miyamoto, Y; Nanri, M; Nishioka, B; Oguro, A; Yamane, E | 1 |
| Aiba, K; Azekura, K; Kokudo, N; Matsubara, T; Moroguchi, A; Nakajima, T; Ohta, H; Sato, T; Seki, M; Takahashi, T; Ueno, M | 1 |
| Asakura, H; Ebe, Y; Ichida, T; Ishikawa, T; Ishimoto, Y; Naito, M; Nomoto, M; Usuda, H; Yokoyama, J | 1 |
| Hoshino, K; Ikeda, H; Koyama, T; Morishita, Y; Nakamura, M | 1 |
| Abad, A; Antón, A; Aranda, E; Carrato, A; Cervantes, A; Díáz-Rubio, E; Fernández Martos, C; Gallén, M; Marcuello, E; Massuti, T; Navarro, M; Rifá, J; Sastre, J | 1 |
| Fujioka, M; Idezuki, Y; Inokuma, S; Ishida, H; Kamano, T; Kishi, T; Kondo, K; Matsumoto, Y; Miura, T; Murata, N; Nakada, H; Odaka, A; Shimomura, K; Suzuki, T; Takeuchi, I; Yamada, H | 1 |
| Kondo, M; Takahashi, S; Takemura, T; Yoshikawa, T | 1 |
| Nakano, H; Nishinuma, T; Sadou, S; Tsurui, H; Watanabe, A; Watanabe, T; Yamada, T | 1 |
| Amagase, Y; Imamura, M; Inoue, Y; Itaba, S; Koujima, M; Miyagi, Y; Motosato, K; Sadamoto, Y; Sato, T; Siomichi, S | 1 |
| Amano, J; Hanazaki, K; Koide, N; Matsunaga, Y; Shiohara, E; Terasaki, T | 1 |
| Kusunoki, M; Noda, M; Yamamura, T; Yanagi, H; Yoshikawa, R | 2 |
| Baba, H; Kikunaga, H; Matsudo, A; Miura, H; Morisue, A; Nakai, H; Osakabe, Y; Sotome, K; Takao, M | 1 |
| Asahara, T; Nakahara, H; Nakahara, M; Okajima, M; Yano, M | 1 |
| Azumi, Y; Hashimoto, Y; Onoyama, H; Saitoh, Y; Sugihara, S; Takao, S; Urakawa, T | 1 |
| Hamazaki, K; Inagaki, M; Kawashima, T; Morichika, T; Sadamori, H; Shima, Y; Tanaka, N; Uetsuka, H; Yagi, T | 1 |
| Aoki, T; Kaise, H; Koyanagi, Y; Kusama, M; Nakayama, S; Oota, D; Shimizu, H | 1 |
| Kobayashi, A; Yamaguchi, M | 1 |
| Fukunaga, M; Goda, F; Maeba, T; Maeta, H; Mihara, T; Mori, S; Ohkawa, M; Okada, H; Okano, K; Senda, S; Uchida, Y; Usuki, H; Wakabayashi, H | 1 |
| Dono, K; Eguchi, H; Gotoh, M; Kishimoto, S; Miyamoto, A; Monden, M; Nagano, H; Nakamori, S; Sakon, M; Umeshita, K | 1 |
| Aoyagi, S; Hisamatsu, T; Ikezawa, T; Matsuoka, K; Mizuno, Y; Motohashi, Y; Nishida, J; Tatsuno, S | 1 |
| Haseme, E; Kikuchi, K; Ohnishi, Y; Shohkei, O | 1 |
| Ikeda, S; Iwamoto, M; Nagata, S; Niiya, F; Shirouzu, K | 1 |
| Ishikawa, T; Matsui, S; Matsuki, H; Matsuzawa, J; Mita, Y; Sato, S; Tashiro, K; Tashiro, S | 1 |
| Asakura, H; Genda, T; Ichida, T; Inayoshi, J; Ishikawa, T; Ishimoto, Y; Sugahara, S; Sugitani, S; Tsuboi, Y; Uehara, K; Yokoyama, J | 1 |
| Akagi, Y; Kobayashi, H; Matono, K; Miyagi, Y; Nakagawa, M; Nozoe, Y; Ogata, Y; Sasatomi, T; Shirouzu, K | 1 |
| Aboagye, EO; Cunningham, VJ; Osman, S; Price, PM; Saleem, A | 1 |
| Bruix, J; Castells, L; El-Hariry, I; Llovet, JM; Peachey, M; Ruff, P; Tassopoulos, N | 1 |
| Chang, W; Kondo, Y; Maeda, S; Matsusaka, S; Okada, T; Oriyama, T; Satake, M; Son, G | 1 |
| Aguayo, A; Patt, YZ | 1 |
| Ishihama, H | 1 |
| Aoyagi, H; Fukue, M; Ikezawa, K; Kodaira, Y; Maruyama, T; Matsui, S; Monma, E; Nozue, M; Sakamoto, T; Shidara, S; Shimakura, S; Takada, Y; Yoshida, T | 1 |
| Ioka, Z; Nakane, Y; Nakano, K; Osaka, Y; Sako, H; Takemura, N; Tanabe, S; Tsuchiya, K | 1 |
| Daijo, H; Hoshino, T; Inokuma, S; Ishida, H; Nakada, H; Ohsawa, T; Takeuchi, I | 1 |
| Dan, T; Kitayama, Y; Kosaka, H; Maeda, S; Matsusaka, S; Okada, T; Tanabe, H; Yamasaki, H | 1 |
| Abramson, N; Benson, AB; Bonny, T; Burnhan, JP; Hohneker, J; Klencke, B; Levin, J; McGuirt, C; Mitchell, E; Ritch, P | 1 |
| Ikeda, M; Kuriyama, H; Okada, S; Okusaka, T; Ueno, H | 1 |
| Plagemann, PG; Zylka, JM | 1 |
| Bhargava, PM; Bornecque, CA; Szafarz, D; Zajdela, F | 1 |
| Blocker, R; Roth, JS | 1 |
| Anghileri, LJ; Heidbreder, M; Mathes, R | 1 |
| Tamemasa, O; Tezuka, M | 1 |
| Marz, R; Plagemann, PG; Wohlhueter, RM | 1 |
| Kamata, T; Kojima, J; Monna, T | 2 |
| Fujita, I; Kiyama, T; Kyono, S; Mizutani, T; Nishi, K; Okazaki, S; Okuda, T; Onda, M; Teramoto, T; Tokunaga, A | 1 |
| Fushida, S; Kaji, M; Kosaka, T; Matsumoto, H; Muraoka, K; Nakai, M; Segawa, M; Takano, Y; Tsugawa, K; Yonemura, Y | 1 |
| Fukushima, W; Hirosawa, H; Kadoya, N; Konishi, K; Kuroda, Y; Sahara, H; Saitoh, F; Taniya, T; Tsuji, M; Yabushita, K | 1 |
| Funakoshi, A; Kono, A; Shimazoe, T | 1 |
| Hatayama, H; Kitamura, H; Mashiko, H; Satoh, J | 1 |
| Bandou, H; Kobayashi, T; Mura, T; Nomura, T; Watanabe, K | 1 |
| Fujii, S; Iwamoto, S; Kotake, H; Mashiba, H; Murai, N; Okuno, F; Sawada, Y; Yurino, N | 1 |
| Aoyama, H; Chiba, Y; Fukushi, G; Fukushi, M; Kimura, M; Matsukawa, M; Sakata, Y; Sato, T; Sawada, Y; Wada, K | 1 |
| Fujimaki, M; Kurokawa, M; Kuroki, Y; Ochiai, H; Okamoto, M; Tazawa, K; Yamashita, I | 1 |
| Hayashi, H; Hazama, S; Murakami, T; Oka, M; Suzuki, T | 1 |
| Hizuta, A; Kataoka, K; Kawaguchi, H; Matumoto, M; Miyagi, K; Nagata, Y; Sou, J; Takahashi, M; Yamamoto, M; Yunoki, S | 1 |
| Fujimura, T; Fushida, S; Kamata, T; Matuki, N; Matumoto, H; Sawa, T; Takegawa, S; Tsugawa, K; Urade, M; Yonemura, Y | 1 |
| Hasegawa, Y; Honnma, S; Nakashima, Y; Takanashi, K; Yajima, K | 1 |
| Fujimoto, H; Ohkusa, T; Ohtomo, K; Yamamoto, N | 1 |
| Amemiya, A; Emoto, T; Fujii, M; Han, N; Itou, A; Iwasaki, T; Tsujimura, T; Yoshikawa, K | 1 |
| Houjo, K; Kawano, N; Moriya, Y; Sugihara, K | 1 |
| Mai, M; Ogino, T; Ohta, T; Ooi, A; Takahashi, Y | 1 |
| Hayashi, K; Ishikawa, T; Ishinoda, Y; Iwaki, Y; Kisanuki, H; Kitamura, T; Maruyama, T; Nakamura, H; Okamoto, T; Shigehira, M | 1 |
| Hayashi, T; Kitagawa, S; Nakagawa, M; Yamada, T | 1 |
| Fujimura, T; Fushida, Y; Kamata, T; Miyazaki, I; Takegawa, S; Urade, M; Yonemura, Y | 1 |
| Hirosawa, H; Katayama, K; Matsuki, N; Sakuma, H; Sawa, T; Takano, N; Tanaka, T; Tomita, F; Ueno, K; Uogishi, M | 1 |
| Ito, Y; Matsuoka, S; Misawa, K; Nagafuchi, E; Nakajima, Y; Ogasawara, K; Sato, N; Uchino, J; Une, Y | 1 |
| Hayashi, K; Hidaka, Y; Kitamura, T; Maruyama, T; Nakamura, H; Nakatsuru, K; Shigehira, M; Tsuda, K | 1 |
| Kuroda, K; Maeda, S; Nagase, T; Nakagawa, C; Nakanishi, T; Nishikawa, M; Tokunaga, K | 1 |
| Suenaga, M | 1 |
| Arase, Y; Chayama, K; Ikeda, K; Irimoto, M; Kumada, H; Murashima, N; Nakajima, M; Nakamura, I; Takeuchi, K; Yoshiba, A | 1 |
| Fujita, M; Furukawa, H; Hirose, N; Imaoka, S; Ishikawa, O; Iwanaga, T; Koyama, H; Ohigashi, H; Sasaki, Y; Shibata, T | 1 |
| Arase, Y; Chayama, K; Gunji, T; Ikeda, K; Irimoto, M; Kumada, H; Yoshiba, A | 1 |
| McIvor, RS; Plagemann, PP; Wohlhueter, RM | 1 |
| Kawakami, H; Nakanishi, T | 1 |
| Ando, B; Ando, S; Ibayashi, H; Inoue, K; Koga, S | 1 |
| Imai, Y; Inada, M; Inui, Y; Kawata, S; Matsuda, Y; Minami, Y; Miyoshi, S; Noda, S; Saito, R; Tamura, S | 1 |
| Matsuo, SK; Ohmura, K; Ohtsuka, Y; Suzuki, M | 1 |
| Oguma, S; Ouchi, K; Owada, Y; Sakai, K; Sato, R; Sato, T | 1 |
| Kagaya, H; Matsuoka, S; Miyata, S; Nagabuchi, E; Sato, Y; Uchino, J; Une, Y; Yakura, Y | 1 |
| Hirata, T; Tsuruhara, Y; Yamauchi, S | 1 |
| Kawahara, M; Matsuo, T; Nagamatsu, Y; Nakarai, I; Shinoda, A | 1 |
| Arai, Y; Endo, T; Kido, C; Miyake, Y; Ozawa, H; Sato, Y | 1 |
| Nomoto, K; Taniguchi, M; Togami, M; Tsuru, S | 1 |
| Ganes, DA; Wagner, JG | 1 |
| Arai, Y; Endo, T; Kido, C; Ota, K; Suyama, K | 1 |
| Hanawa, S; Hara, S; Joya, K; Nakata, K; Sato, K; Shigemitsu, M | 1 |
| Miller, RL; Plagemann, PG | 1 |
| Boctor, A; Grossman, A | 2 |
| Alexander, JA; Hill, DD; Morris, HP; Wheeler, GP | 1 |
| Görlich, M; Heise, E | 1 |
| Aksamitnaia, IA; Silina, LA | 1 |
| Plagemann, PG | 1 |
| Bresnick, E; Liebelt, AG; Liebelt, RA; Mayfield, ED | 1 |
| Bukharova, IK; Larionov, LF | 1 |
| Ansfield, FJ; Dexter, DL; Heidelberger, C; Helson, L; Wolberg, WH | 1 |
| Chudinova, IA; Davidova, SY; Gorozhanskaya, EG; Krechetova, GD; Shapot, VS; Vornovitskaya, GI; Zhubanova, AA | 1 |
| Busch, H; Choi, YC; Henning, D; Reddy, R; Ro-Choi, TS; Shibata, H | 1 |
| Pitot, HC; Wilkinson, DS | 1 |
| Garcia, H; Mirvish, SS | 1 |
| Bullock, J; Khalil, FL; Lea, MA; Morris, HP | 1 |
| Morris, HP; Queener, SF; Weber, G | 1 |
| Klimenko, GA | 1 |
| Heidelberger, C | 1 |
| Wacker, A | 1 |
| Reynolds, VH; Van Way, CW | 1 |
17 review(s) available for uracil and Cancer of Liver
| Article | Year |
|---|---|
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosphate; Adsorption; Adult; Africa, Eastern; Aged; Air Pollutants; Air Pollution; Air Pollution, Indoor; Alcohol Drinking; Allergens; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Anti-Bacterial Agents; Antibodies; Antibodies, Immobilized; Antigen Presentation; Antigens, CD; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Aptamers, Nucleotide; Asthma; Asthma, Exercise-Induced; Atrophy; Autophagy; Azoospermia; Bacillus cereus; Bacterial Infections; Beclin-1; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biofouling; Biological Monitoring; Biomarkers; Biomarkers, Tumor; Biosensing Techniques; Blastocyst; Bone Neoplasms; Bone Regeneration; Bronchoconstriction; Burkitt Lymphoma; C9orf72 Protein; Campylobacter; Campylobacter Infections; Campylobacter jejuni; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Carcinoma, Squamous Cell; Cardiomyopathies; Caregivers; Carmine; Case-Control Studies; Catalysis; Cattle; Cause of Death; CCAAT-Enhancer-Binding Protein-alpha; CD8-Positive T-Lymphocytes; Cefepime; Cell Differentiation; Cell Line, Tumor; Cell Nucleus; Cell Transdifferentiation; Chelating Agents; Chemical and Drug Induced Liver Injury, Chronic; Chemoradiotherapy, Adjuvant; Child; Child, Preschool; China; Chlorquinaldol; Cholangiocarcinoma; Cholera; Chromatin; Clinical Trials as Topic; Cognitive Dysfunction; Cohort Studies; Colonic Neoplasms; Colorectal Neoplasms; Colorimetry; Cooking; Coordination Complexes; COVID-19; Creatinine; CRISPR-Cas Systems; Critical Care; Critical Illness; Cross-Sectional Studies; Cryopreservation; Cryoprotective Agents; Cysteine; Cytokines; Device Removal; Diet; Diet, High-Fat; Diet, Mediterranean; Dietary Supplements; Dimethyl Sulfoxide; Dipeptides; Disease Models, Animal; Dithiothreitol; DNA; DNA Repeat Expansion; DNA, Bacterial; DNA, Complementary; Dopamine; Electrochemical Techniques; Electrodes; Endocannabinoids; Environmental Exposure; Environmental Monitoring; Environmental Pollutants; Enzyme-Linked Immunosorbent Assay; Erlotinib Hydrochloride; Escherichia coli; Escherichia coli O157; Esophageal Neoplasms; Esophagitis, Peptic; Ethylene Glycol; Europium; Exanthema; Fallopian Tubes; Feces; Female; Fertilization in Vitro; Fluoresceins; Fluorescent Dyes; Follicle Stimulating Hormone; Follow-Up Studies; Food Microbiology; Forced Expiratory Volume; Forkhead Transcription Factors; Frontotemporal Dementia; G-Quadruplexes; Galactose; Gastroenteritis; Gastrointestinal Diseases; Gastrointestinal Microbiome; Gastrointestinal Neoplasms; Gastrointestinal Tract; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Genital Neoplasms, Female; Genome-Wide Association Study; Genome, Viral; Genomics; Genotype; Glucose; Glutathione; Glycerol; Gold; Graphite; GTPase-Activating Proteins; Heat-Shock Proteins; Heme Oxygenase-1; Hepacivirus; Hepatitis C; Hepatocytes; Histamine; Histocompatibility Antigens Class II; Hoarseness; Hospice and Palliative Care Nursing; Humans; Hydrogen; Hydrogen Peroxide; Hydrogen Sulfide; Hydroxybenzoates; Hydroxyl Radical; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperthermia, Induced; Hysteroscopy; Immunoassay; Indigo Carmine; Inflammation; Inflammatory Bowel Diseases; Insulin Resistance; Intensive Care Units; Interleukin-11; Interleukin-6; Interleukins; Iodine Radioisotopes; Iran; Iridium; Islets of Langerhans; Kinetics; Lactation; Lactobacillus; Lactobacillus plantarum; Lamins; Latin America; Lead; Lectins; Leukopenia; Ligands; Limit of Detection; Lipopolysaccharides; Lipoprotein Lipase; Liver; Liver Cirrhosis; Liver Neoplasms; Lolium; Luminescent Measurements; Luminol; Lung; Luteinizing Hormone; Macrophages; Magnetic Phenomena; Magnetic Resonance Imaging; Male; Malnutrition; Maltose; Manganese Compounds; Maternal Nutritional Physiological Phenomena; Melatonin; Metabolic Engineering; Metal Nanoparticles; Metallocenes; Metaplasia; Methicillin-Resistant Staphylococcus aureus; Methylation; Mevalonic Acid; Mexico; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microbial Sensitivity Tests; Microbiota; MicroRNAs; Milk; Mitomycin; Molecular Diagnostic Techniques; Molecular Docking Simulation; Monte Carlo Method; Moringa oleifera; Multiple Sclerosis; Muscle Strength; Muscle, Skeletal; Nanocomposites; Nanotubes, Carbon; Neoadjuvant Therapy; Neoplasms; Neurodegenerative Diseases; Neurotransmitter Agents; NF-E2-Related Factor 2; Nickel; Nitrogen Dioxide; Non-alcoholic Fatty Liver Disease; Nucleic Acid Amplification Techniques; Nucleic Acid Hybridization; Nucleocapsid Proteins; Nutritional Status; Obesity; Osteogenesis; Osteosarcoma; Oxidation-Reduction; Oxides; Oxygen; Oxyquinoline; Pain; Palliative Care; Pancreatic Neoplasms; Pandemics; Particulate Matter; Peroxidase; Peroxidases; Phagocytosis; Phaseolus; Photothermal Therapy; Point-of-Care Systems; Polyethyleneimine; Polymers; Polymorphism, Single Nucleotide; Polysomnography; Postoperative Complications; Pregnancy; Pregnant Women; Prenatal Exposure Delayed Effects; Prevalence; Printing, Three-Dimensional; Probability; Probiotics; Prognosis; Prophages; Prospective Studies; Proteomics; Proto-Oncogene Proteins; Pseudomonas aeruginosa; Pseudomonas putida; Pulmonary Disease, Chronic Obstructive; Pulmonary Embolism; Pyridines; Pyrroles; Quality of Life; Quinolones; Rabbits; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Receptors, Histamine; Receptors, Histamine H2; Recombinases; Rectal Neoplasms; Reperfusion Injury; Respiration; Respiratory Function Tests; Respiratory Rate; Respiratory Sounds; Retrospective Studies; rho GTP-Binding Proteins; Risk Assessment; Risk Factors; RNA; RNA, Messenger; RNA, Ribosomal, 16S; Robotic Surgical Procedures; Running; Rural Population; Saccharomyces cerevisiae; Salpingectomy; Sarcopenia; SARS-CoV-2; Seeds; Semen; Sensitivity and Specificity; Sepsis; Shock, Septic; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Skin Neoplasms; Sleep Apnea, Obstructive; Soil; Spain; Spectrum Analysis, Raman; Sperm Retrieval; Spermatozoa; Spirometry; Staphylococcus aureus; STAT3 Transcription Factor; Stereoisomerism; Sterilization, Tubal; Stroke Volume; Sulfadiazine; Sulfites; Superoxide Dismutase; Surface Plasmon Resonance; tau Proteins; Testis; Testosterone; Thioredoxin-Disulfide Reductase; Thyroid Neoplasms; Thyroidectomy; Trans-Activators; Transcription Factor AP-1; Treatment Outcome; Triazoles; Triclosan; Trifluridine; Tumor Microenvironment; Tumor Necrosis Factor-alpha; United States; Uracil; Vagina; Vegetables; Ventricular Function, Left; Ventricular Pressure; Vibrio cholerae; Vietnam; Virulence; Vital Capacity; Vitrification; Walking; Water; Water Pollutants, Radioactive; Whole Genome Sequencing; Wind; YAP-Signaling Proteins; Zeolites; Zinc Oxide | 2023 |
[Complete remission of hepatocellular carcinoma with multiple lung metastases by oral administration of tegafur/uracil].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Lung Neoplasms; Male; Remission Induction; Tegafur; Uracil | 2013 |
ABT-450: a novel agent for the treatment of CHC genotype 1: focus on treatment-experienced patients.
Topics: 2-Naphthylamine; Anilides; Antiviral Agents; Carbamates; Carcinoma, Hepatocellular; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cyclopropanes; Drug Interactions; Drug Resistance, Viral; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Lactams, Macrocyclic; Liver Cirrhosis; Liver Neoplasms; Macrocyclic Compounds; Proline; Protease Inhibitors; Randomized Controlled Trials as Topic; Ribavirin; Ritonavir; RNA, Viral; Sulfonamides; Uracil; Valine | 2015 |
[New era in the treatment of chronic hepatitis C - novel direct acting antivirals].
Topics: 2-Naphthylamine; Administration, Oral; Anilides; Antiviral Agents; Benzimidazoles; Carbamates; Clinical Trials as Topic; Cyclopropanes; Drug Therapy, Combination; Fluorenes; Hepacivirus; Hepatitis C, Chronic; Heterocyclic Compounds, 3-Ring; Humans; Imidazoles; Interferons; Isoquinolines; Lactams, Macrocyclic; Liver Neoplasms; Macrocyclic Compounds; Nucleic Acid Synthesis Inhibitors; Proline; Protease Inhibitors; Pyrrolidines; Simeprevir; Sofosbuvir; Sulfonamides; Uracil; Uridine Monophosphate; Valine; Viral Load; Viral Nonstructural Proteins; Virus Replication | 2015 |
Advances in the treatment of metastatic colorectal cancer.
Topics: Administration, Oral; Antibodies, Monoclonal; Antineoplastic Agents; Camptothecin; Cancer Vaccines; Capecitabine; Colorectal Neoplasms; Deoxycytidine; Drug Administration Schedule; Fluorouracil; Humans; Irinotecan; Liver Neoplasms; Neoplasm Metastasis; Organoplatinum Compounds; Oxaliplatin; Prodrugs; Quinazolines; Randomized Controlled Trials as Topic; Thiophenes; Uracil | 2001 |
Palliative treatment of patients with colorectal cancer.
Topics: Antimetabolites, Antineoplastic; Camptothecin; Colorectal Neoplasms; Disease Progression; Enzyme Inhibitors; Fluorouracil; Humans; Irinotecan; Leucovorin; Liver Neoplasms; Palliative Care; Quinazolines; Survival Analysis; Tegafur; Thiophenes; Thymidylate Synthase; Topoisomerase I Inhibitors; Treatment Outcome; Uracil | 2003 |
[Complete disappearance with oral UFT administration of recurrent hepatocellular carcinoma of the remnant liver and multiple lung metastasis after hepatic resection].
Topics: Administration, Oral; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Biomarkers, Tumor; Carcinoma, Hepatocellular; Drug Administration Schedule; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Protein Precursors; Prothrombin; Tegafur; Uracil | 2003 |
[Chemotherapy for colorectal carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colorectal Neoplasms; Drug Administration Schedule; Drug Combinations; Fluorouracil; Humans; Irinotecan; Leucovorin; Liver Neoplasms; Prospective Studies; Randomized Controlled Trials as Topic; Tegafur; Uracil | 2003 |
[Recent progress in chemotherapy for hepatocellular carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemotherapy, Adjuvant; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; Disease Progression; Doxorubicin; Drug Interactions; Embolization, Therapeutic; Fluorouracil; Hepatectomy; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Interferon-alpha; Liver Neoplasms; Organoplatinum Compounds; Oxaliplatin; Tamoxifen; Tegafur; Uracil | 2004 |
Chemotherapy with enteric-coated tegafur/uracil for advanced hepatocellular carcinoma.
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Tablets, Enteric-Coated; Tegafur; Treatment Outcome; Uracil | 2008 |
Intraarterial infusion chemotherapy for unresectable hepatic metastases from colorectal cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Liver Neoplasms; Mitomycin; Survival Rate; Tegafur; Uracil | 1996 |
[A noteworthy case of postoperative liver metastasis from gastric cancer which responded well to UFT therapy].
Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Gastrectomy; Humans; Liver Neoplasms; Male; Postoperative Period; Remission Induction; Stomach Neoplasms; Tegafur; Uracil | 2000 |
Nonsurgical treatment of hepatocellular carcinoma.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Capecitabine; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cryosurgery; Deoxycytidine; Drug Combinations; Ethanol; Fluorouracil; Humans; Hyperthermia, Induced; Infusions, Intra-Arterial; Injections, Intralesional; Interferons; Liver Cirrhosis; Liver Neoplasms; Octreotide; Radiopharmaceuticals; Radiotherapy Dosage; Tamoxifen; Tegafur; Uracil | 2001 |
[A case of liver metastasis of gastric cancer which was made resectable by hypertheromo-chemo-radiotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Female; Hepatectomy; Humans; Hyperthermia, Induced; Liver Neoplasms; Middle Aged; Mitomycins; Remission Induction; Stomach Neoplasms; Tegafur; Uracil | 1989 |
Notes on some peculiarities of enzymic processes in malignant tumours and tissues of the host.
Topics: Adenine; Animals; Carbon Isotopes; Carcinoma, Hepatocellular; Catalase; Cholesterol; DNA, Neoplasm; Humans; Isoenzymes; L-Lactate Dehydrogenase; Leukemia, Lymphoid; Leukemia, Myeloid; Leukocytes; Liver; Liver Neoplasms; Lymphocytes; Neoplasms; Neoplasms, Experimental; Orotic Acid; Pyrimidine Nucleotides; Rats; RNA, Neoplasm; Uracil | 1972 |
Chemical carcinogenesis, chemotherapy: cancer's continuing core challenges--G. H. A. Clowes Memorial Lecture.
Topics: Animals; Antineoplastic Agents; Arginase; Benz(a)Anthracenes; Benzopyrenes; Carcinogens; Cell Division; Cell Transformation, Neoplastic; Deoxyribonucleases; DNA; Fluorouracil; Humans; Liver Neoplasms; Methylcholanthrene; Mice; Mutation; Neoplasms; Neoplasms, Experimental; Nucleosides; Oncogenic Viruses; Orotic Acid; Phenanthrenes; Protein Binding; Pyrimidinones; Rats; Skin Neoplasms; Thymine; Uracil | 1970 |
[Recent aspects of antiviral therapy].
Topics: Animals; Antibody Formation; Cattle; Chick Embryo; Chickens; Child; Herpes Zoster Ophthalmicus; Humans; Interferon Inducers; Interferons; Leukemia; Liver Neoplasms; Lymphoma; Mice; Plasmacytoma; RNA; Sarcoma; Species Specificity; Splenic Neoplasms; Uracil; Vaccines; Virus Diseases | 1971 |
49 trial(s) available for uracil and Cancer of Liver
| Article | Year |
|---|---|
Phase I prospective trial of TAS-102 (trifluridine and tipiracil) and radioembolization with
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Combinations; Female; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Prospective Studies; Trifluridine; Uracil | 2022 |
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosphate; Adsorption; Adult; Africa, Eastern; Aged; Air Pollutants; Air Pollution; Air Pollution, Indoor; Alcohol Drinking; Allergens; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Anti-Bacterial Agents; Antibodies; Antibodies, Immobilized; Antigen Presentation; Antigens, CD; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Aptamers, Nucleotide; Asthma; Asthma, Exercise-Induced; Atrophy; Autophagy; Azoospermia; Bacillus cereus; Bacterial Infections; Beclin-1; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biofouling; Biological Monitoring; Biomarkers; Biomarkers, Tumor; Biosensing Techniques; Blastocyst; Bone Neoplasms; Bone Regeneration; Bronchoconstriction; Burkitt Lymphoma; C9orf72 Protein; Campylobacter; Campylobacter Infections; Campylobacter jejuni; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Carcinoma, Squamous Cell; Cardiomyopathies; Caregivers; Carmine; Case-Control Studies; Catalysis; Cattle; Cause of Death; CCAAT-Enhancer-Binding Protein-alpha; CD8-Positive T-Lymphocytes; Cefepime; Cell Differentiation; Cell Line, Tumor; Cell Nucleus; Cell Transdifferentiation; Chelating Agents; Chemical and Drug Induced Liver Injury, Chronic; Chemoradiotherapy, Adjuvant; Child; Child, Preschool; China; Chlorquinaldol; Cholangiocarcinoma; Cholera; Chromatin; Clinical Trials as Topic; Cognitive Dysfunction; Cohort Studies; Colonic Neoplasms; Colorectal Neoplasms; Colorimetry; Cooking; Coordination Complexes; COVID-19; Creatinine; CRISPR-Cas Systems; Critical Care; Critical Illness; Cross-Sectional Studies; Cryopreservation; Cryoprotective Agents; Cysteine; Cytokines; Device Removal; Diet; Diet, High-Fat; Diet, Mediterranean; Dietary Supplements; Dimethyl Sulfoxide; Dipeptides; Disease Models, Animal; Dithiothreitol; DNA; DNA Repeat Expansion; DNA, Bacterial; DNA, Complementary; Dopamine; Electrochemical Techniques; Electrodes; Endocannabinoids; Environmental Exposure; Environmental Monitoring; Environmental Pollutants; Enzyme-Linked Immunosorbent Assay; Erlotinib Hydrochloride; Escherichia coli; Escherichia coli O157; Esophageal Neoplasms; Esophagitis, Peptic; Ethylene Glycol; Europium; Exanthema; Fallopian Tubes; Feces; Female; Fertilization in Vitro; Fluoresceins; Fluorescent Dyes; Follicle Stimulating Hormone; Follow-Up Studies; Food Microbiology; Forced Expiratory Volume; Forkhead Transcription Factors; Frontotemporal Dementia; G-Quadruplexes; Galactose; Gastroenteritis; Gastrointestinal Diseases; Gastrointestinal Microbiome; Gastrointestinal Neoplasms; Gastrointestinal Tract; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Genital Neoplasms, Female; Genome-Wide Association Study; Genome, Viral; Genomics; Genotype; Glucose; Glutathione; Glycerol; Gold; Graphite; GTPase-Activating Proteins; Heat-Shock Proteins; Heme Oxygenase-1; Hepacivirus; Hepatitis C; Hepatocytes; Histamine; Histocompatibility Antigens Class II; Hoarseness; Hospice and Palliative Care Nursing; Humans; Hydrogen; Hydrogen Peroxide; Hydrogen Sulfide; Hydroxybenzoates; Hydroxyl Radical; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperthermia, Induced; Hysteroscopy; Immunoassay; Indigo Carmine; Inflammation; Inflammatory Bowel Diseases; Insulin Resistance; Intensive Care Units; Interleukin-11; Interleukin-6; Interleukins; Iodine Radioisotopes; Iran; Iridium; Islets of Langerhans; Kinetics; Lactation; Lactobacillus; Lactobacillus plantarum; Lamins; Latin America; Lead; Lectins; Leukopenia; Ligands; Limit of Detection; Lipopolysaccharides; Lipoprotein Lipase; Liver; Liver Cirrhosis; Liver Neoplasms; Lolium; Luminescent Measurements; Luminol; Lung; Luteinizing Hormone; Macrophages; Magnetic Phenomena; Magnetic Resonance Imaging; Male; Malnutrition; Maltose; Manganese Compounds; Maternal Nutritional Physiological Phenomena; Melatonin; Metabolic Engineering; Metal Nanoparticles; Metallocenes; Metaplasia; Methicillin-Resistant Staphylococcus aureus; Methylation; Mevalonic Acid; Mexico; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microbial Sensitivity Tests; Microbiota; MicroRNAs; Milk; Mitomycin; Molecular Diagnostic Techniques; Molecular Docking Simulation; Monte Carlo Method; Moringa oleifera; Multiple Sclerosis; Muscle Strength; Muscle, Skeletal; Nanocomposites; Nanotubes, Carbon; Neoadjuvant Therapy; Neoplasms; Neurodegenerative Diseases; Neurotransmitter Agents; NF-E2-Related Factor 2; Nickel; Nitrogen Dioxide; Non-alcoholic Fatty Liver Disease; Nucleic Acid Amplification Techniques; Nucleic Acid Hybridization; Nucleocapsid Proteins; Nutritional Status; Obesity; Osteogenesis; Osteosarcoma; Oxidation-Reduction; Oxides; Oxygen; Oxyquinoline; Pain; Palliative Care; Pancreatic Neoplasms; Pandemics; Particulate Matter; Peroxidase; Peroxidases; Phagocytosis; Phaseolus; Photothermal Therapy; Point-of-Care Systems; Polyethyleneimine; Polymers; Polymorphism, Single Nucleotide; Polysomnography; Postoperative Complications; Pregnancy; Pregnant Women; Prenatal Exposure Delayed Effects; Prevalence; Printing, Three-Dimensional; Probability; Probiotics; Prognosis; Prophages; Prospective Studies; Proteomics; Proto-Oncogene Proteins; Pseudomonas aeruginosa; Pseudomonas putida; Pulmonary Disease, Chronic Obstructive; Pulmonary Embolism; Pyridines; Pyrroles; Quality of Life; Quinolones; Rabbits; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Receptors, Histamine; Receptors, Histamine H2; Recombinases; Rectal Neoplasms; Reperfusion Injury; Respiration; Respiratory Function Tests; Respiratory Rate; Respiratory Sounds; Retrospective Studies; rho GTP-Binding Proteins; Risk Assessment; Risk Factors; RNA; RNA, Messenger; RNA, Ribosomal, 16S; Robotic Surgical Procedures; Running; Rural Population; Saccharomyces cerevisiae; Salpingectomy; Sarcopenia; SARS-CoV-2; Seeds; Semen; Sensitivity and Specificity; Sepsis; Shock, Septic; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Skin Neoplasms; Sleep Apnea, Obstructive; Soil; Spain; Spectrum Analysis, Raman; Sperm Retrieval; Spermatozoa; Spirometry; Staphylococcus aureus; STAT3 Transcription Factor; Stereoisomerism; Sterilization, Tubal; Stroke Volume; Sulfadiazine; Sulfites; Superoxide Dismutase; Surface Plasmon Resonance; tau Proteins; Testis; Testosterone; Thioredoxin-Disulfide Reductase; Thyroid Neoplasms; Thyroidectomy; Trans-Activators; Transcription Factor AP-1; Treatment Outcome; Triazoles; Triclosan; Trifluridine; Tumor Microenvironment; Tumor Necrosis Factor-alpha; United States; Uracil; Vagina; Vegetables; Ventricular Function, Left; Ventricular Pressure; Vibrio cholerae; Vietnam; Virulence; Vital Capacity; Vitrification; Walking; Water; Water Pollutants, Radioactive; Whole Genome Sequencing; Wind; YAP-Signaling Proteins; Zeolites; Zinc Oxide | 2023 |
Long-term safety and efficacy results in hepatitis C virus genotype 1-infected patients receiving ombitasvir/paritaprevir/ritonavir + dasabuvir ± ribavirin in the TOPAZ-I and TOPAZ-II trials.
Topics: 2-Naphthylamine; Anilides; Antiviral Agents; Carcinoma, Hepatocellular; Cyclopropanes; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C; Humans; Lactams, Macrocyclic; Liver Neoplasms; Proline; Ribavirin; Ritonavir; Sulfonamides; Sustained Virologic Response; Uracil; Valine | 2020 |
The impact of liver resection on the dihydrouracil:uracil plasma ratio in patients with colorectal liver metastases.
Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Colorectal Neoplasms; Female; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Uracil | 2018 |
Cost-effectiveness Analysis of Regorafenib and TAS-102 in Refractory Metastatic Colorectal Cancer in the United States.
Topics: Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Cost-Benefit Analysis; Double-Blind Method; Drug Combinations; Drug Resistance, Neoplasm; Follow-Up Studies; Humans; Liver Neoplasms; Markov Chains; Palliative Care; Phenylurea Compounds; Prognosis; Pyridines; Pyrrolidines; Quality-Adjusted Life Years; Salvage Therapy; Survival Rate; Thymine; Trifluridine; United States; Uracil | 2018 |
Celecoxib plus chemoradiotherapy for locally advanced rectal cancer: a phase II TCOG study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Celecoxib; Chemoradiotherapy, Adjuvant; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Disease-Free Survival; Dose Fractionation, Radiation; Female; Humans; Immunohistochemistry; Leucovorin; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Prognosis; Pyrazoles; Rectal Neoplasms; Rectum; Sulfonamides; Tegafur; Uracil | 2014 |
A combination of oral uracil-tegafur plus leucovorin (UFT + LV) is a safe regimen for adjuvant chemotherapy after hepatectomy in patients with colorectal cancer: safety report of the UFT/LV study.
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Disease-Free Survival; Female; Hepatectomy; Humans; Japan; Kaplan-Meier Estimate; Leucovorin; Liver Neoplasms; Male; Middle Aged; Tegafur; Time Factors; Treatment Outcome; Uracil | 2014 |
Administration of adjuvant oral tegafur/uracil chemotherapy post hepatocellular carcinoma resection: A randomized controlled trial.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemotherapy, Adjuvant; Female; Follow-Up Studies; Hepatectomy; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Survival Analysis; Tegafur; Treatment Outcome; Uracil; Young Adult | 2016 |
Adjuvant Oral Uracil-Tegafur with Leucovorin for Colorectal Cancer Liver Metastases: A Randomized Controlled Trial.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Disease-Free Survival; Female; Humans; Leucovorin; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Tegafur; Treatment Outcome; Uracil | 2016 |
Phase II study of UFT with leucovorin plus hepatic arterial infusion with irinotecan, 5-fluorouracil and leucovorin for non-resectable liver metastases of colorectal cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colorectal Neoplasms; Dihydrouracil Dehydrogenase (NADP); Female; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Irinotecan; Leucovorin; Liver Neoplasms; Male; Middle Aged; Tegafur; Uracil | 2009 |
Phase II study of combining sorafenib with metronomic tegafur/uracil for advanced hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Carcinoma, Hepatocellular; Diarrhea; Disease-Free Survival; Drug Eruptions; Fatigue; Female; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Sorafenib; Tegafur; Uracil | 2010 |
Phase I/II study of irinotecan, UFT and leucovorin with hepatic arterial infusion using 5-FU in colorectal cancer patients with unresectable liver metastases.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colorectal Neoplasms; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Irinotecan; Leucovorin; Liver Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Survival Rate; Tegafur; Treatment Outcome; Uracil | 2011 |
A phase I/II study of combined chemotherapy with mitoxantrone and uracil/tegafur for advanced hepatocellular carcinoma.
Topics: Adrenal Gland Neoplasms; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Hepatocellular; Cohort Studies; Female; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Mitoxantrone; Neoplasm Staging; Peritoneal Neoplasms; Survival Rate; Tegafur; Treatment Outcome; Uracil | 2011 |
Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Biomarkers; Carcinoma, Hepatocellular; Contrast Media; Feasibility Studies; Female; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neovascularization, Pathologic; Niacinamide; Phenylurea Compounds; Predictive Value of Tests; Pyridines; Sorafenib; Tegafur; Uracil; Young Adult | 2011 |
Final results of a prematurely discontinued Phase 1/2 study of eniluracil with escalating doses of 5-fluorouracil administered orally in patients with advanced hepatocellular carcinoma.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Asian People; Carcinoma, Hepatocellular; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Fluorouracil; Humans; Liver Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Treatment Outcome; Uracil | 2011 |
Uracil-tegafur/leucovorin and mitomycin C salvage therapy in patients with advanced colorectal cancer: a phase II study.
Topics: Adult; Aged; Aged, 80 and over; Anorexia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asthenia; Colorectal Neoplasms; Drug Combinations; Drug Monitoring; Female; Humans; Leucovorin; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Grading; Salvage Therapy; Survival Analysis; Tegafur; Tumor Burden; Uracil | 2012 |
Phase I clinical trial of a peptide vaccine combined with tegafur-uracil plus leucovorin for treatment of advanced or recurrent colorectal cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cancer Vaccines; Colorectal Neoplasms; Combined Modality Therapy; Disease-Free Survival; Female; Humans; Immunotherapy, Active; Kaplan-Meier Estimate; Leucovorin; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; T-Lymphocytes, Cytotoxic; Tegafur; Treatment Outcome; Uracil; Vaccines, Subunit | 2013 |
Eastern Cooperative Oncology Group phase II trial (E4296) of oral 5-fluorouracil and eniluracil as a 28-day regimen in metastatic colorectal cancer.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Confidence Intervals; Drug Administration Schedule; Enzyme Inhibitors; Female; Fluorouracil; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Survival Analysis; Uracil | 2002 |
[Hepatic recurrence after prophylactic hepatic arterial infusion of 5-fluorouracil for Dukes' C colorectal cancer--correlation with the expression of dihydropyrimidine dehydrogenase in the primary tumor].
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Dihydrouracil Dehydrogenase (NADP); Enzyme-Linked Immunosorbent Assay; Fluorouracil; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Neoplasm Recurrence, Local; Oxidoreductases; Tegafur; Uracil | 2002 |
Prediction of sensitivity to fluoropyrimidines by metabolic and target enzyme activities in gastric cancer.
Topics: Adult; Aged; Aged, 80 and over; Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Therapy; Dihydrouracil Dehydrogenase (NADP); Drug Combinations; Female; Fluorouracil; Gastrectomy; Humans; Japan; Liver Neoplasms; Lymphatic Metastasis; Male; Mice; Mice, Inbred BALB C; Middle Aged; Multivariate Analysis; Neoplasm Staging; Oxidoreductases; Oxonic Acid; Peritoneal Neoplasms; Predictive Value of Tests; Pyridines; Retrospective Studies; Statistics as Topic; Stomach Neoplasms; Survival Analysis; Tegafur; Thymidine Phosphorylase; Thymidylate Synthase; Treatment Outcome; Uracil | 2003 |
[Clinical usefulness of UFT and cyclophosphamide as salvage chemotherapy for patients with metastatic breast cancer].
Topics: Administration, Oral; Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Drug Administration Routes; Drug Combinations; Female; Humans; Leukopenia; Liver Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Salvage Therapy; Skin Neoplasms; Tegafur; Thrombocytopenia; Uracil | 2004 |
[Pharmacokinetic modulating chemotherapy highly effective for colorectal carcinoma metastases to multiple organs].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Chronotherapy; Colorectal Neoplasms; Drug Combinations; Female; Fluorouracil; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Leucovorin; Liver Neoplasms; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Tegafur; Uracil | 2005 |
Phase II study on low dose gemcitabine plus oral chemotherapy with uracil-tegafur and cyclophosphamide in combination with radiotherapy against recurrent and advanced pancreatic cancer.
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Constipation; Cyclophosphamide; Deoxycytidine; Diarrhea; Dose-Response Relationship, Drug; Female; Fever; Follow-Up Studies; Gemcitabine; Humans; Leukopenia; Liver Neoplasms; Male; Middle Aged; Nausea; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Radiotherapy; Survival Rate; Tegafur; Thrombocytopenia; Treatment Outcome; Uracil | 2005 |
Phase II study with a combination of epirubicin, cisplatin, UFT, and leucovorin in advanced hepatocellular carcinoma.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antidotes; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Dose-Response Relationship, Drug; Epirubicin; Female; Hematologic Diseases; Humans; Leucovorin; Liver Neoplasms; Male; Middle Aged; Survival Analysis; Tegafur; Tomography, X-Ray Computed; Treatment Outcome; Uracil | 2006 |
[Clinical evaluation of chemotherapy with irinotecan (CPT-11), l-leucovorin (l-LV), 5-fluorouracil (5-FU), and UFT for metastatic or recurrent colorectal cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colonic Neoplasms; Drug Administration Schedule; Drug Combinations; Female; Fluorouracil; Humans; Irinotecan; Leucovorin; Liver Neoplasms; Male; Middle Aged; Nausea; Rectal Neoplasms; Survival Rate; Tegafur; Uracil; Vomiting, Anticipatory | 2005 |
Early phase II study of uracil-tegafur plus doxorubicin in patients with unresectable advanced biliary tract cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biliary Tract Neoplasms; Cholangiocarcinoma; Doxorubicin; Drug Administration Schedule; Fatigue; Female; Gallbladder Neoplasms; Humans; Leukopenia; Liver Neoplasms; Male; Middle Aged; Nausea; Survival Rate; Tegafur; Uracil | 2006 |
Uracil-tegafur as an adjuvant for hepatocellular carcinoma: a randomized trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemotherapy, Adjuvant; Disease-Free Survival; Female; Follow-Up Studies; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Survival Rate; Tegafur; Uracil | 2006 |
Phase II study of cisplatin, epirubicin, UFT, and leucovorin (PELUF) as first-line chemotherapy in metastatic gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Epirubicin; Female; Follow-Up Studies; Humans; Leucovorin; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Peritoneal Neoplasms; Stomach Neoplasms; Survival Analysis; Tegafur; Time Factors; Treatment Outcome; Uracil | 2007 |
Improved survival for hepatocellular carcinoma with portal vein tumor thrombosis treated by intra-arterial chemotherapy combining etoposide, carboplatin, epirubicin and pharmacokinetic modulating chemotherapy by 5-FU and enteric-coated tegafur/uracil: a p
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Hepatocellular; Chemotherapy, Cancer, Regional Perfusion; Epirubicin; Etoposide; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Pilot Projects; Portal Vein; Prospective Studies; Severity of Illness Index; Tablets, Enteric-Coated; Tegafur; Time Factors; Treatment Outcome; Uracil; Venous Thrombosis | 2007 |
A phase II study of tegafur plus uracil or tegafur alone for the treatment of advanced hepatocellular carcinoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Female; Humans; Liver Neoplasms; Male; Tegafur; Uracil | 2008 |
Adjuvant chemotherapy with tegafur/uracil administration after transcatheter arterial chemoembolization for advanced hepatocellular carcinoma.
Topics: Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Humans; Liver Neoplasms; Male; Middle Aged; Necrosis; Proportional Hazards Models; Tegafur; Treatment Outcome; Uracil | 2008 |
A prospective randomized evaluation of a compound of tegafur and uracil as an adjuvant chemotherapy for hepatocellular carcinoma treated with transcatheter arterial chemoembolization.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Chemotherapy, Adjuvant; Drug Combinations; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Remission Induction; Survival Analysis; Tegafur; Uracil | 1995 |
[The significance of portal infusion chemotherapy for prevention of recurrence in residual liver after hepatectomy for metastases from colorectal cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Female; Fluorouracil; Hepatectomy; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Infusions, Intravenous; Liver Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Neoplasm, Residual; Portal Vein; Tegafur; Uracil | 1994 |
Combination chemotherapy with Tegafur. Uracil (UFT), etoposide, adriamycin and cisplatinum (UFT-EAP) for advanced gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cisplatin; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Leukopenia; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Nausea; Stomach Neoplasms; Survival Analysis; Tegafur; Uracil | 1994 |
A pharmacological pilot study: application of an intermittent schedule of oral uracil and ftorafur (UFT) for hepatocellular carcinoma patients.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Carcinoma, Hepatocellular; Female; Hepatectomy; Humans; Kidney Function Tests; Liver Function Tests; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Pilot Projects; Tegafur; Uracil | 1996 |
UFT plus leucovorin in advanced hepatobiliary tumors and pancreatic adenocarcinomas.
Topics: Adenocarcinoma; Adult; Antidotes; Antineoplastic Combined Chemotherapy Protocols; Cholangiocarcinoma; Drug Combinations; Humans; Leucovorin; Liver Neoplasms; Pancreatic Neoplasms; Quality of Life; Tegafur; Treatment Outcome; Uracil | 1997 |
A crossover study of oral administration of UFT in chronic liver disease: comparison of continuous and intermittent schedules.
Topics: Administration, Oral; Aged; Area Under Curve; Carcinoma, Hepatocellular; Chronic Disease; Cross-Over Studies; Diarrhea; Drug Administration Schedule; Drug Combinations; Female; Fluorouracil; Gastritis; Gastrointestinal Hemorrhage; Humans; Liver Diseases; Liver Neoplasms; Male; Middle Aged; Nausea; Tegafur; Treatment Outcome; Uracil | 1998 |
UFT plus or minus calcium folinate for metastatic colorectal cancer in older patients.
Topics: Adenocarcinoma; Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Leucovorin; Liver Neoplasms; Male; Retrospective Studies; Survival Rate; Tegafur; Treatment Outcome; Uracil | 1999 |
[Clinical trial of prophylactic hepatic arterial chemotherapy for liver metastases in patients with Dukes' C colorectal cancer].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Administration Schedule; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Neoplasm Staging; Prospective Studies; Tegafur; Uracil | 1999 |
Results of pharmacokinetic modulating chemotherapy in combination with hepatic arterial 5-fluorouracil infusion and oral UFT after resection of hepatic colorectal metastases.
Topics: Administration, Oral; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Synergism; Female; Fluorouracil; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Prospective Studies; Survival Analysis; Tegafur; Treatment Outcome; Uracil | 2000 |
Improved survival with oral administration of enteric-coated tegafur/uracil for advanced stage IV-A hepatocellular carcinoma.
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Carcinoma, Hepatocellular; Drug Combinations; Female; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Survival Analysis; Tablets, Enteric-Coated; Tegafur; Uracil | 2001 |
A phase II trial of oral eniluracil/5-fluorouracil in patients with inoperable hepatocellular carcinoma.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Female; Fluorouracil; Follow-Up Studies; Humans; Liver Neoplasms; Male; Middle Aged; Survival Rate; Uracil | 2001 |
Oral eniluracil/5-fluorouracil in patients with inoperable hepatocellular carcinoma.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Diarrhea; Enzyme Inhibitors; Female; Fluorouracil; Humans; Liver Neoplasms; Male; Middle Aged; Treatment Outcome; Uracil | 2002 |
Phase II study of uracil-tegafur in patients with metastatic pancreatic cancer.
Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Pancreatic Neoplasms; Peritoneal Neoplasms; Tegafur; Treatment Outcome; Uracil | 2002 |
[Randomized trial-comparing UFT and FT in the treatment of advanced hepatocellular carcinoma (second report: well controlled study on patients with transcatheter arterial embolization) Osaka Research Society for Liver, Gallbladder and Pancreas].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Middle Aged; Prognosis; Survival Rate; Tegafur; Uracil | 1992 |
[Comparative study of UFT plus mitomycin C and UFT plus doxorubicin in adenocarcinoma. Hirosaki Cooperative Group of Cancer Chemotherapy].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Doxorubicin; Drug Administration Schedule; Female; Humans; Liver Neoplasms; Male; Middle Aged; Mitomycin; Pancreatic Neoplasms; Stomach Neoplasms; Survival Rate; Tegafur; Uracil; Vomiting | 1992 |
[Randomized trial comparing UFT and FT-207 in the treatment of advanced hepatocellular carcinoma (first report: well controlled study on the patients for whom transcatheter arterial embolization could not be applied) Osaka Research Society for Liver, Gall
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Middle Aged; Multicenter Studies as Topic; Prognosis; Randomized Controlled Trials as Topic; Survival Rate; Tegafur; Uracil | 1990 |
[Effect of PMU hepatic arterial chemotherapy for liver metastases of gastric cancer. Hokuriku Cisplatin Round-table Conference].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Drug Evaluation; Female; Hepatic Artery; Humans; Injections, Intra-Arterial; Japan; Liver Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Multicenter Studies as Topic; Remission Induction; Stomach Neoplasms; Tegafur; Uracil | 1989 |
The clinical pharmacology of 5-trifluoromethyl-2'-deoxyuridine.
Topics: Adult; Aged; Antineoplastic Agents; Carbon Dioxide; Carbon Isotopes; Carcinoma, Hepatocellular; Clinical Trials as Topic; Female; Fibrosarcoma; Fluorides; Half-Life; Hodgkin Disease; Humans; Leukemia; Liver Neoplasms; Male; Middle Aged; Neuroblastoma; Nucleosides; Retinoblastoma; Uracil | 1972 |
242 other study(ies) available for uracil and Cancer of Liver
| Article | Year |
|---|---|
The effect of prognostic factors at baseline on the efficacy of trifluridine/tipiracil in patients with metastatic colorectal cancer: A Portuguese exploratory analysis.
Topics: Aged; Colonic Neoplasms; Colorectal Neoplasms; Female; Humans; Liver Neoplasms; Male; Portugal; Prognosis; Pyrrolidines; Rectal Neoplasms; Retrospective Studies; Thymine; Trifluridine; Uracil | 2022 |
Overexpression of nucleotide metabolic enzyme DUT in hepatocellular carcinoma potentiates a therapeutic opportunity through targeting its dUTPase activity.
Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Humans; Liver Neoplasms; NF-kappa B; Nucleotides; Pyrophosphatases; Sorafenib; Uracil | 2022 |
[A Case Report of a Patient Over 90 Years of Age with Liver Metastasis after Sigmoid Colectomy Controlled by a Combination Oral UFT/LV Chemotherapy Regimen].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Colectomy; Female; Humans; Leucovorin; Liver Neoplasms; Sigmoid Neoplasms; Tegafur; Uracil | 2019 |
Application of advanced HepG2 3D cell model for studying genotoxic activity of cyanobacterial toxin cylindrospermopsin.
Topics: Alkaloids; Animals; Arylamine N-Acetyltransferase; Bacterial Toxins; Cyanobacteria Toxins; DNA Damage; Hep G2 Cells; Humans; Liver Neoplasms; Marine Toxins; Microcystins; Uracil | 2020 |
Simultaneous quantification method for 5-FU, uracil, and tegafur using UPLC-MS/MS and clinical application in monitoring UFT/LV combination therapy after hepatectomy.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Calibration; Chromatography, High Pressure Liquid; Colorectal Neoplasms; Drug Monitoring; Fluorouracil; Hepatectomy; Humans; Leucovorin; Liver; Liver Neoplasms; Sensitivity and Specificity; Tandem Mass Spectrometry; Tegafur; Uracil | 2021 |
Attenuation of diethyl nitrosamine-induced hepatocellular carcinoma by taxifolin and/or alogliptin: The interplay between toll-like receptor 4, transforming growth factor beta-1, and apoptosis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Carcinoma, Hepatocellular; Diethylnitrosamine; Gene Expression Regulation; Hypoglycemic Agents; Liver Neoplasms; Male; Piperidines; Quercetin; Random Allocation; Rats; Rats, Wistar; Toll-Like Receptor 4; Transforming Growth Factor beta1; Uracil | 2021 |
Genetic variants of DNA repair-related genes predict efficacy of TAS-102 in patients with refractory metastatic colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Colorectal Neoplasms; Disease-Free Survival; DNA Repair Enzymes; Drug Combinations; Drug Resistance, Neoplasm; Female; Genetic Association Studies; Humans; Liver Neoplasms; Male; Middle Aged; Phenylurea Compounds; Proportional Hazards Models; Pyridines; Pyrrolidines; Retrospective Studies; Thymine; Treatment Outcome; Trifluridine; Uracil | 2017 |
Tegafur-uracil-induced rapid development of advanced hepatic fibrosis.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Ascites; Biopsy; Carcinoma, Hepatocellular; Diuretics; Female; Humans; Hypertension, Portal; Liver; Liver Cirrhosis; Liver Neoplasms; Tegafur; Time Factors; Tomography, X-Ray Computed; Uracil; Withholding Treatment | 2017 |
Propensity Score Analysis of Regorafenib Versus Trifluridine/Tipiracil in Patients with Metastatic Colorectal Cancer Refractory to Standard Chemotherapy (REGOTAS): A Japanese Society for Cancer of the Colon and Rectum Multicenter Observational Study.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Colorectal Neoplasms; Drug Combinations; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Humans; Japan; Liver Neoplasms; Male; Middle Aged; Phenylurea Compounds; Prognosis; Propensity Score; Pyridines; Pyrrolidines; Retrospective Studies; Salvage Therapy; Survival Rate; Thymine; Trifluridine; Uracil | 2018 |
Successful twice interrupted therapy of HCV infection in patients with cirrhosis with hepatocellular carcinoma before and after liver transplantation.
Topics: 2-Naphthylamine; Anilides; Antiviral Agents; Carbamates; Carcinoma, Hepatocellular; Cyclopropanes; Drug Therapy, Combination; Hepatitis C; Humans; Lactams, Macrocyclic; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Macrocyclic Compounds; Male; Middle Aged; Proline; Ribavirin; Ritonavir; Sulfonamides; Sustained Virologic Response; Treatment Outcome; Uracil; Valine | 2017 |
Genotoxic potential of the binary mixture of cyanotoxins microcystin-LR and cylindrospermopsin.
Topics: Alkaloids; Bacterial Toxins; Carcinogens; Carcinoma, Hepatocellular; Cyanobacteria; Cyanobacteria Toxins; DNA Damage; Eutrophication; Humans; Liver Neoplasms; Marine Toxins; Microcystins; Micronucleus Tests; Mutagenicity Tests; Uracil; Water Pollutants, Chemical | 2017 |
[Safety and Efficacy of TAS-102 with Bevacizumab for the Treatment of Unresectable Metastatic Colorectal Cancer - A Case Report].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Drug Combinations; Humans; Liver Neoplasms; Male; Pyrrolidines; Rectal Neoplasms; Thymine; Treatment Outcome; Trifluridine; Uracil | 2018 |
Durability of virologic response, risk of de novo hepatocellular carcinoma, liver function and stiffness 2 years after treatment with ombitasvir/paritaprevir/ritonavir±dasabuvir±ribavirin in the AMBER, real-world experience study.
Topics: 2-Naphthylamine; Adult; Aged; Anilides; Antiviral Agents; Carbamates; Carcinoma, Hepatocellular; Cyclopropanes; Drug Therapy, Combination; Female; Follow-Up Studies; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Lactams, Macrocyclic; Liver; Liver Cirrhosis; Liver Neoplasms; Macrocyclic Compounds; Male; Middle Aged; Poland; Proline; Ribavirin; Ritonavir; Sulfonamides; Treatment Outcome; Uracil; Valine; Viral Load | 2018 |
Concomitant use of sorafenib with ombitasvir/paritaprevir/ritonavir and dasabuvir: Effectiveness and safety in clinical practice.
Topics: 2-Naphthylamine; Aged; Anilides; Antineoplastic Agents; Antiviral Agents; Carbamates; Carcinoma, Hepatocellular; Cyclopropanes; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Lactams, Macrocyclic; Liver Neoplasms; Macrocyclic Compounds; Male; Middle Aged; Proline; Prospective Studies; Ritonavir; Sorafenib; Sulfonamides; Treatment Outcome; Uracil; Valine | 2018 |
Optimizing Treatment Sequence for Late-line Metastatic Colorectal Cancer Patients Using Trifluridine/Tipiracil and Regorafenib.
Topics: Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Administration Schedule; Drug Combinations; Female; Follow-Up Studies; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Phenylurea Compounds; Prognosis; Pyridines; Pyrrolidines; Retrospective Studies; Survival Rate; Thymine; Trifluridine; Uracil | 2018 |
Role of Predictive Value of the Modified Glasgow Prognostic Score for Later-line Chemotherapy in Patients With Metastatic Colorectal Cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; C-Reactive Protein; Colorectal Neoplasms; Drug Combinations; Female; Follow-Up Studies; Humans; Liver Neoplasms; Male; Middle Aged; Nutritional Status; Phenylurea Compounds; Prognosis; Pyridines; Pyrrolidines; Retrospective Studies; Serum Albumin, Human; Survival Rate; Thymine; Trifluridine; Uracil | 2018 |
Relationship Between Thymidine Kinase 1 Expression and Trifluridine/Tipiracil Therapy in Refractory Metastatic Colorectal Cancer: A Pooled Analysis of 2 Randomized Clinical Trials.
Topics: Aged; Antineoplastic Agents; Colorectal Neoplasms; Drug Combinations; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Humans; Liver Neoplasms; Male; Prognosis; Pyrrolidines; Randomized Controlled Trials as Topic; Salvage Therapy; Survival Rate; Thymidine Kinase; Thymine; Trifluridine; Uracil | 2018 |
[A Case of Interstitial Pneumonitis Induced by TAS-102 for Liver and Lung Metastasis of Colorectal Cancer].
Topics: Aged; Drug Combinations; Humans; Liver Neoplasms; Lung Diseases, Interstitial; Lung Neoplasms; Male; Pyrrolidines; Rectal Neoplasms; Sigmoid Neoplasms; Thymine; Treatment Outcome; Trifluridine; Uracil | 2018 |
A 12-year Recurrence-free Survival After Multidisciplinary Treatment for a Patient With Combined Hepatocellular-Cholangiocarcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Carcinoma, Hepatocellular; Cholangiocarcinoma; Cisplatin; Disease-Free Survival; Female; Fluorouracil; Gamma Rays; Hepatectomy; Humans; Liver Neoplasms; Middle Aged; Mitomycin; Tegafur; Uracil | 2019 |
Recurrence rate of hepatocellular carcinoma in patients with treated hepatocellular carcinoma and hepatitis C virus-associated cirrhosis after ombitasvir/paritaprevir/ritonavir+dasabuvir+ribavirin therapy.
Topics: 2-Naphthylamine; Aged; Anilides; Antiviral Agents; Carbamates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cyclopropanes; Hepatectomy; Hepatitis C, Chronic; Humans; Lactams, Macrocyclic; Liver Cirrhosis; Liver Neoplasms; Macrocyclic Compounds; Middle Aged; Neoplasm Recurrence, Local; Proline; Prospective Studies; Radiofrequency Ablation; Ribavirin; Ritonavir; Sulfonamides; Treatment Outcome; Uracil; Valine | 2019 |
Genetic polymorphisms of enzymes related to oral tegafur/uracil therapeutic efficacy in patients with hepatocellular carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Aryl Hydrocarbon Hydroxylases; Asian People; Carcinoma, Hepatocellular; Cytochrome P-450 CYP2A6; Dihydrouracil Dehydrogenase (NADP); Female; Fluorouracil; Genotype; Hepatitis C; Humans; Japan; Liver Neoplasms; Male; Minisatellite Repeats; Polymorphism, Genetic; Tegafur; Thymidylate Synthase; Uracil | 2013 |
Association between reversal of multidrug resistance by methyl jasmonate and P-glycoprotein ATPase activity in hepatocellular carcinoma.
Topics: Acetates; Adenosine Triphosphate; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Cisplatin; Cyclopentanes; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Injections, Intraperitoneal; Liver Neoplasms; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Oxylipins; Survival Analysis; Tegafur; Uracil; Verapamil | 2013 |
A novel role of the tumor suppressor GNMT in cellular defense against DNA damage.
Topics: Adenosine; Animals; Carbon Radioisotopes; Carcinoma, Hepatocellular; Cell Nucleus; Cells, Cultured; Chromatography, High Pressure Liquid; Dietary Supplements; DNA Damage; DNA Methylation; Female; Fluorescent Antibody Technique, Indirect; Folic Acid; Glycine N-Methyltransferase; Hepatocytes; Homocysteine; Humans; Liver; Liver Neoplasms; Male; Methylenetetrahydrofolate Dehydrogenase (NADP); Mice; Mice, Knockout; Minor Histocompatibility Antigens; Protein Transport; Purines; Pyrimidines; S-Adenosylhomocysteine; S-Adenosylmethionine; Tetrahydrofolates; Uracil | 2014 |
Ombitasvir, paritaprevir, ritonavir, dasabuvir and ribavirin in cirrhosis after complete destruction of hepatocellular carcinoma.
Topics: 2-Naphthylamine; Aged; Anilides; Antiviral Agents; Carbamates; Carcinoma, Hepatocellular; Cyclopropanes; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C; Humans; Lactams, Macrocyclic; Liver Cirrhosis; Liver Function Tests; Liver Neoplasms; Macrocyclic Compounds; Male; Proline; Ribavirin; Ritonavir; RNA, Viral; Sulfonamides; Treatment Outcome; Uracil; Valine; Viral Load | 2016 |
Cost-effectiveness of currently recommended direct-acting antiviral treatments in patients infected with genotypes 1 or 4 hepatitis C virus in the US.
Topics: 2-Naphthylamine; Adult; Aged; Aged, 80 and over; Anilides; Antiviral Agents; Benzimidazoles; Carbamates; Carcinoma, Hepatocellular; Cost-Benefit Analysis; Cyclopropanes; Drug Therapy, Combination; Female; Fibrosis; Fluorenes; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Lactams, Macrocyclic; Liver Neoplasms; Macrocyclic Compounds; Male; Markov Chains; Middle Aged; Models, Econometric; Proline; Quality-Adjusted Life Years; Ribavirin; Simeprevir; Sofosbuvir; Sulfonamides; Uracil; Valine | 2016 |
Cost-Effectiveness of Genotype 1 Chronic Hepatitis C Virus Treatments in Patients Coinfected with Human Immunodeficiency Virus in the United States.
Topics: 2-Naphthylamine; Adult; Anilides; Antiviral Agents; Benzimidazoles; Carbamates; Carcinoma, Hepatocellular; Cost-Benefit Analysis; Cyclopropanes; Disease Progression; Drug Therapy, Combination; Fluorenes; Genotype; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Interferon-alpha; Lactams, Macrocyclic; Liver Cirrhosis; Liver Neoplasms; Macrocyclic Compounds; Markov Chains; Middle Aged; Polyethylene Glycols; Proline; Quality-Adjusted Life Years; Recombinant Proteins; Ribavirin; Ritonavir; Sofosbuvir; Sulfonamides; United States; Uracil; Valine | 2016 |
[A Case of Metastatic Colorectal Cancer Refractory to Standard Chemotherapies Treated with TAS-102 with Bevacizumab].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Combined Modality Therapy; Drug Combinations; Female; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Pyrrolidines; Sigmoid Neoplasms; Thymine; Treatment Outcome; Trifluridine; Uracil | 2016 |
Effectiveness, safety and clinical outcomes of direct-acting antiviral therapy in HCV genotype 1 infection: Results from a Spanish real-world cohort.
Topics: 2-Naphthylamine; Adult; Aged; Aged, 80 and over; Anilides; Antiviral Agents; Benzimidazoles; Carbamates; Carcinoma, Hepatocellular; Cohort Studies; Cyclopropanes; Drug Therapy, Combination; Female; Fluorenes; Genotype; Glomerular Filtration Rate; Hepacivirus; Hepatitis C, Chronic; Humans; Lactams, Macrocyclic; Liver Neoplasms; Macrocyclic Compounds; Male; Middle Aged; Neoplasm Recurrence, Local; Proline; Retrospective Studies; Ribavirin; Ritonavir; Sofosbuvir; Spain; Sulfonamides; Sustained Virologic Response; Treatment Outcome; Uracil; Uridine Monophosphate; Valine; Young Adult | 2017 |
[A case of simultaneous hepatic metastases of ascending colon cancer responding completely to tegafur/uracil plus oral Leucovorin therapy after primary lesion resection].
Topics: Administration, Oral; Aged, 80 and over; Colonic Neoplasms; Female; Humans; Leucovorin; Liver Neoplasms; Magnetic Resonance Imaging; Tegafur; Uracil | 2008 |
[A case of multiple liver metastases of sigmoid colon cancer responding well to UFT+Leucovorin therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Leucovorin; Liver Neoplasms; Magnetic Resonance Imaging; Radiography; Sigmoid Neoplasms; Tegafur; Ultrasonography; Uracil | 2008 |
[A case of metastatic lung and liver tumors from rectal cancer treated with oral UFT and CPT-11 by hepatic arterial infusion followed by FOLFOX and FOLFIRI].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Camptothecin; Fluorouracil; Humans; Infusions, Intra-Arterial; Irinotecan; Leucovorin; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Rectal Neoplasms; Tegafur; Tomography, X-Ray Computed; Uracil | 2008 |
[Regression of metastatic hepatic cancer from gastric cancer by polysaccharide K and UFT administration--a case report].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Humans; Liver Neoplasms; Male; Polysaccharides; Stomach Neoplasms; Tegafur; Tomography, X-Ray Computed; Uracil | 2008 |
[A case of metastatic pancreatic cancer after combination chemotherapy with uracil-tegafur and gemcitabine].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Deoxycytidine; Fatal Outcome; Gemcitabine; Humans; Liver Neoplasms; Male; Pancreatic Neoplasms; Tegafur; Tomography, X-Ray Computed; Uracil | 2009 |
[A case of multiple hepatic metastases of gastric cancer that showed complete regression by systemic chemotherapy using paclitaxel and UFT-E].
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; CA-19-9 Antigen; Carcinoembryonic Antigen; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Paclitaxel; Stomach Neoplasms; Tegafur; Tomography, X-Ray Computed; Uracil | 2009 |
Complete remission of multiple recurrent hepatocellular carcinomas by oral administration of enteric-coated tegafur/uracil in a patient with huge hepatocellular carcinoma extending to the inferior vena cava after hepatic resection: analysis of mRNA expres
Topics: Administration, Oral; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Combined Modality Therapy; Dihydrouracil Dehydrogenase (NADP); Hepatectomy; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Orotate Phosphoribosyltransferase; RNA, Messenger; Tegafur; Thymidine Phosphorylase; Thymidylate Synthase; Uracil; Vena Cava, Inferior | 2009 |
[A case of disease-free survival with low-dose chemotherapy after resection of hepatic and pulmonary metastases from rectal cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Hepatectomy; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Pneumonectomy; Rectal Neoplasms; Tegafur; Uracil | 2009 |
[A case report of multiple liver metastases from colorectal cancer effectively treated with systemic chemotherapy and hepatic arterial infusion].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Hepatectomy; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Irinotecan; Leucovorin; Liver Neoplasms; Male; Middle Aged; Sigmoid Neoplasms; Tegafur; Uracil | 2009 |
[A case report of combined hepatocellular-cholangiocarcinoma whose lymph node recurrence effectively treated with UFT].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarcinoma; Combined Modality Therapy; Embolization, Therapeutic; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Tegafur; Uracil | 2009 |
[Multiple liver metastases due to sigmoid colon cancer successfully treated by degradable starch microspheres (DSM)-TAE, radiofrequency ablation therapy, and Uzel/UFT].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoembryonic Antigen; Catheter Ablation; Combined Modality Therapy; Humans; Leucovorin; Liver Neoplasms; Male; Microspheres; Remission Induction; Sigmoid Neoplasms; Starch; Tegafur; Tomography, X-Ray Computed; Uracil | 2010 |
[A case of complete response after treatment with UFT and leucovorin for synchronous multiple liver metastases of rectal cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Leucovorin; Liver Neoplasms; Magnetic Resonance Imaging; Middle Aged; Neoplasm Staging; Rectal Neoplasms; Remission Induction; Tegafur; Tomography, X-Ray Computed; Uracil | 2010 |
[A case of fluoropyrimidine-resistant recurrent colon cancer successfully treated with weekly administration of irinotecan].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoembryonic Antigen; Colonic Neoplasms; Drug Resistance, Neoplasm; Humans; Irinotecan; Leucovorin; Liver Neoplasms; Male; Neoplasm Staging; Recurrence; Tegafur; Tomography, X-Ray Computed; Uracil | 2010 |
[A case of hepatocellular carcinoma with autoimmune hepatitis showing marked reduction of tumors by oral administration of UFT-E].
Topics: Administration, Oral; Aged; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Carcinoma, Hepatocellular; Hepatitis, Autoimmune; Humans; Liver Neoplasms; Male; Radiography; Tegafur; Uracil | 2010 |
[A case of hepatocellular carcinoma with portal vein thrombus(Vp3)and lung metastases(stage IVB),which responded completely to treatment with Tegafur/Uracil].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Female; Humans; Liver Neoplasms; Lung Neoplasms; Neoplasm Staging; Portal Vein; Remission Induction; Tegafur; Thrombosis; Tomography, X-Ray Computed; Uracil | 2010 |
Lethal outcome of 5-fluorouracil infusion in a patient with a total DPD deficiency and a double DPYD and UTG1A1 gene mutation.
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Colonic Neoplasms; Dihydropyrimidine Dehydrogenase Deficiency; Dihydrouracil Dehydrogenase (NADP); Fatal Outcome; Fluorouracil; Humans; Infusion Pumps; Liver Neoplasms; Male; Mutation; Phenotype; Uracil | 2010 |
[A case of advanced rectal cancer with multiple liver metastases successfully treated by perioperative administration of UFT and oral leucovorin].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hepatectomy; Humans; Leucovorin; Liver Neoplasms; Male; Neoplasm Staging; Rectal Neoplasms; Tegafur; Tomography, X-Ray Computed; Uracil | 2010 |
[A case of recurrent sigmoid colon cancer with adrenal and para-aortic lymph node metastasis successfully treated by operation and chemotherapy].
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Aorta; Bevacizumab; Camptothecin; Combined Modality Therapy; Female; Fluorouracil; Hepatectomy; Humans; Irinotecan; Leucovorin; Liver Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Organoplatinum Compounds; Sigmoid Neoplasms; Tegafur; Uracil | 2010 |
[Hepatic resection after systemic chemotherapy for liver metastasis of colorectal cancer].
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Cetuximab; Colorectal Neoplasms; Combined Modality Therapy; Drug Administration Schedule; Hepatectomy; Humans; Irinotecan; Length of Stay; Liver Neoplasms; Middle Aged; Neoadjuvant Therapy; Organoplatinum Compounds; Oxaliplatin; Tegafur; Uracil | 2010 |
[A case of synchronous hepatic and multiple pulmonary metastases from rectal cancer responding completely to UFT therapy after resection of primary and hepatic lesions].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Humans; Liver Neoplasms; Lung Neoplasms; Middle Aged; Rectal Neoplasms; Remission Induction; Tegafur; Tomography, X-Ray Computed; Uracil | 2011 |
[A case of marked efficacy of low-dose UFT against metastatic bladder cancer].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Invasiveness; Recurrence; Tegafur; Tomography, X-Ray Computed; Uracil; Urinary Bladder Neoplasms | 2011 |
[A case of UFT-induced complete response against multiple lung metastases of hepatocarcinoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Lung Neoplasms; Male; Remission Induction; Tegafur; Tomography, X-Ray Computed; Uracil | 2011 |
[A case of synchronous multiple liver metastases of rectal cancer successfully treated with tegafur/uracil and oral leucovorin chemotherapy].
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Humans; Leucovorin; Liver Neoplasms; Male; Rectal Neoplasms; Tegafur; Tomography, X-Ray Computed; Uracil | 2011 |
[The feasibility of oral fluoropyrimidines as adjuvant chemotherapy after resection and local coagulation therapy of colorectal liver metastases].
Topics: Administration, Oral; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Drug Combinations; Electrocoagulation; Female; Humans; Liver Neoplasms; Male; Middle Aged; Oxonic Acid; Survival Rate; Tegafur; Uracil | 2011 |
[A case of pathological complete response after treatment with uracil/tegafur (UFT) and folinate (Leucovorin) for liver metastasis of colon cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Combined Modality Therapy; Female; Humans; Leucovorin; Liver Neoplasms; Middle Aged; Remission Induction; Tegafur; Uracil | 2011 |
[A case of laparoscopic radiofrequency ablation for liver metastatic tumor from colorectal carcinoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Catheter Ablation; Colonic Neoplasms; Female; Humans; Laparoscopy; Leucovorin; Liver Neoplasms; Tegafur; Tomography, X-Ray Computed; Uracil | 2011 |
[Marked response to oral administration of UFT and leucovorin for liver metastases from colon cancer in an elderly patient].
Topics: Administration, Oral; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Humans; Leucovorin; Liver Neoplasms; Male; Tegafur; Tomography, X-Ray Computed; Uracil | 2012 |
[A case of liver metastases of sigmoid colon cancer treated effectively by oral UFT/LV].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Leucovorin; Liver Neoplasms; Sigmoid Neoplasms; Tegafur; Tomography, X-Ray Computed; Uracil | 2012 |
[A case of successful treatment of granulocyte colony-stimulating factor producing hepatocellular carcinoma accompanying type B hepatitis with tegafur-uracil].
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Granulocyte Colony-Stimulating Factor; Hepatitis B, Chronic; Humans; Liver Neoplasms; Male; Tegafur; Uracil | 2012 |
[CPT-11 hepatic arterial injection plus oral UFT administration for liver metastasis of rectal cancer--report of two cases].
Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Drug Administration Schedule; Drug Combinations; Hepatic Artery; Humans; Injections, Intra-Arterial; Irinotecan; Liver Neoplasms; Male; Middle Aged; Rectal Neoplasms; Tegafur; Uracil | 2002 |
[A case of unresectable rectal cancer with liver and pulmonary metastases that responded remarkably to pharmacokinetic modulating chemotherapy].
Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Fluorouracil; Humans; Infusion Pumps, Implantable; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Quality of Life; Rectal Neoplasms; Tegafur; Uracil | 2002 |
[A patient with hepatocellular carcinoma with intraperitonial lymph node metastases in whom oral UFT treatment was markedly effective].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Female; Humans; Liver Neoplasms; Lymph Nodes; Lymphatic Metastasis; Peritoneum; Tegafur; Uracil | 2002 |
[A case of multiple liver metastases from colon cancer successfully treated with modified pharmacokinetic modulating chemotherapy using Leucovorin].
Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Colectomy; Colonic Neoplasms; Combined Modality Therapy; Drug Administration Schedule; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Male; Middle Aged; Remission Induction; Tegafur; Uracil | 2002 |
[A case of postoperative hepatic metastasis from gastric cancer responding to hepatic arterial infusion chemotherapy of paclitaxel].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Drug Administration Schedule; Drug Combinations; Fluorouracil; Gastrectomy; Humans; Liver Neoplasms; Male; Paclitaxel; Stomach Neoplasms; Tegafur; Uracil | 2002 |
[5-FU pharmacokinetic study of 5-FU hepato-arterial infusion with oral UFT].
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Fluorouracil; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Tegafur; Uracil | 2002 |
[Modified pharmacokinetic modulation chemotherapy (PMC) with medication of UFT and intraarterial infusion of 5-FU for advanced unresectable HCC].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Drug Combinations; Female; Fluorouracil; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Survival Rate; Tegafur; Uracil | 2002 |
Dihydropyrimidine dehydrogenase (DPD) activity in gastric cancer tissue and effect of DPD inhibitory fluoropyrimidines.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Dihydrouracil Dehydrogenase (NADP); Disease Progression; Drug Combinations; Enzyme Inhibitors; Fluorouracil; Humans; Japan; Leucovorin; Liver Neoplasms; Lymphatic Metastasis; Oxidoreductases; Oxonic Acid; Peritoneal Neoplasms; Prognosis; Pyridines; Statistics as Topic; Stomach Neoplasms; Survival Analysis; Tegafur; Treatment Outcome; Uracil | 2003 |
Studies in 2-acetylaminofluorene carcinogenesis. III. The utilization of uracil-2-C14 by preneoplastic rat liver and rat hepatoma.
Topics: 2-Acetylaminofluorene; Animals; Carcinogenesis; Carcinoma, Hepatocellular; Fluorenes; Liver Neoplasms; Neoplasms, Experimental; Rats; Uracil | 1954 |
Utilization of uracil by acetylaminofluorene-treated rats.
Topics: 2-Acetylaminofluorene; Animals; Carcinoma, Hepatocellular; Fluorenes; Liver Neoplasms; Liver Neoplasms, Experimental; Neoplasms, Experimental; Nucleic Acids; Rats; Uracil | 1955 |
Alternative pathways of thymine and uracil metabolism in the liver and hepatoma.
Topics: Carcinoma, Hepatocellular; Humans; Liver; Liver Neoplasms; Thymine; Uracil | 1960 |
Catabolism of xanthine and uracil in tumor-bearing rats.
Topics: Animals; Carcinoma 256, Walker; Carcinoma, Hepatocellular; Hydantoins; Liver Neoplasms; Neoplasms; Neoplasms, Experimental; Oxidoreductases; Rats; Sarcoma, Experimental; Uracil; Uric Acid; Xanthine; Xanthines | 1962 |
[ENZYMATIC STUDIES OF CANCER].
Topics: Carcinoma, Hepatocellular; Fluorenes; Liver; Liver Neoplasms; Metabolism; Neoplasms; Neoplasms, Experimental; Rats; Research; Uracil | 1964 |
RIBONUCLEIC ACID SYNTHESIS AND TURNOVER IN RAT LIVER AND IN A RAPIDLY GROWING TRANSPLANTABLE HEPATOMA.
Topics: Adenine; Carcinoma, Hepatocellular; Cytosine; Electrophoresis; Guanine; Histocytochemistry; Liver; Liver Neoplasms; Metabolism; Neoplasm Transplantation; Neoplasms, Experimental; Rats; Research; RNA; RNA, Neoplasm; Uracil | 1964 |
COMPARISON OF THE URACIL CATABOLIC ACTIVITY OF LIVER CELL SUSPENSIONS AND SLICES.
Topics: Carbon Dioxide; Carbon Isotopes; Carcinoma, Hepatocellular; Hepatocytes; Liver; Liver Neoplasms; Metabolism; Orotic Acid; Perfusion; Rats; Research; RNA; Suspensions; Uracil | 1964 |
PYRIMIDINE METABOLISM IN TISSUE CULTURE CELLS DERIVED FROM RAT HEPATOMAS. I. SUSPENSION CELL CULTURES DERIVED FROM THE NOVIKOFF HEPATOMA.
Topics: Animals; Carcinoma, Hepatocellular; Cell Culture Techniques; Floxuridine; Fluorouracil; Glycine; Liver Neoplasms; Liver Neoplasms, Experimental; Metabolism; Methotrexate; Mutation; Neoplasms; Neoplasms, Experimental; Nucleosides; Pharmacology; Pyrimidines; Rats; Research; Serine; Thymidine; Thymidine Kinase; Thymine; Tissue Culture Techniques; Toxicology; Uracil | 1965 |
[A case of multiple liver metastases from colon cancer successfully treated with pharmacokinetic modulating chemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Drug Administration Schedule; Female; Fluorouracil; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Infusions, Intravenous; Liver Neoplasms; Middle Aged; Tegafur; Uracil | 2003 |
[Results of prophylactic hepatic arterial chemotherapy for liver metastases of Dukes C colorectal cancer--correlation with tumoral expression of dihydropyrimidine dehydrogenase, thymidylate synthase, p53, or orotate phosphoribosyl transferase].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Dihydrouracil Dehydrogenase (NADP); Drug Combinations; Female; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Orotate Phosphoribosyltransferase; Proportional Hazards Models; RNA, Messenger; Tegafur; Thymidylate Synthase; Tumor Suppressor Protein p53; Uracil | 2003 |
[A case of liver and lung metastases of rectal cancer responding well to 5-FU hepato-arterial infusion (HAI) with combined use of oral UFT].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Combinations; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Lung Neoplasms; Male; Rectal Neoplasms; Tegafur; Uracil | 2003 |
[A case of hepatic metastasis and local recurrence from rectal cancer responding to hepatic arterial infusion and systemic chemotherapy].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Drug Administration Schedule; Drug Combinations; Floxuridine; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Irinotecan; Leucovorin; Liver Neoplasms; Male; Neoplasm Recurrence, Local; Rectal Neoplasms; Tegafur; Uracil | 2003 |
[A case of liver metastases from gastric cancer successfully treated with induced hypertensive chemotherapy].
Topics: Aged; Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Blood Pressure; Brain Neoplasms; Combined Modality Therapy; Drug Administration Schedule; Drug Combinations; Gastrectomy; Hepatectomy; Hepatic Artery; Humans; Injections, Intra-Arterial; Liver Neoplasms; Male; Mitomycin; Proteoglycans; Radiosurgery; Stomach Neoplasms; Tegafur; Uracil | 2003 |
[A case of advanced gastric cancer with multiple liver metastases responding completely to hepatic arterial infusion and systemic chemotherapies].
Topics: Adenocarcinoma; Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Drug Combinations; Fluorouracil; Gastrectomy; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Remission Induction; Stomach Neoplasms; Tegafur; Uracil | 2003 |
[A case of liver metastatic recurrence of bile duct cancer completely responding to single drug, UFT, chemotherapy].
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Bile Duct Neoplasms; Common Bile Duct; Drug Administration Schedule; Drug Combinations; Humans; Liver Neoplasms; Male; Radiotherapy, High-Energy; Remission Induction; Tegafur; Uracil | 2004 |
Competitive action of 2-thiouracil and uracil in AAF-induced cancer of the liver.
Topics: Carcinogenesis; Humans; Liver Neoplasms; Neoplasms; Thiouracil; Uracil | 1951 |
A novel antimetabolite, TAS-102 retains its effect on FU-related resistant cancer cells.
Topics: Animals; Antimetabolites; Antimetabolites, Antineoplastic; Cell Line, Tumor; Colorectal Neoplasms; Coloring Agents; Drug Combinations; Drug Resistance, Neoplasm; Fluorouracil; Globins; Humans; Liver; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Models, Chemical; Neoplasm Metastasis; Neoplasm Transplantation; Polymerase Chain Reaction; Pyrrolidines; Sensitivity and Specificity; Tetrazolium Salts; Thiazoles; Thymidine Phosphorylase; Thymine; Trifluridine; Uracil | 2004 |
[A case of gastric cancer with a synchronous hepatic metastasis responding to postoperative oral administration of UFT and intermittent intrahepatic arterial chemotherapy of 5-FU].
Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Combinations; Fluorouracil; Gastrectomy; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Lymph Node Excision; Male; Neoplasms, Multiple Primary; Remission Induction; Stomach Neoplasms; Tegafur; Uracil | 2004 |
[A case of highly advanced ascending colon cancer with multiple bone and liver metastases and pleuritis carcinomatosa treated with pharmacokinetic modulating chemotherapy and low-dose CPT-11].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Camptothecin; Colonic Neoplasms; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Fluorouracil; Humans; Irinotecan; Leucovorin; Liver Neoplasms; Male; Middle Aged; Pleurisy; Quality of Life; Tegafur; Uracil | 2004 |
[Two cases of advanced pancreatic cancer responding to gemcitabine with long survival of 2 years].
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Cholestasis; Deoxycytidine; Drug Administration Schedule; Drug Combinations; Drug Eruptions; Female; Gemcitabine; Heart Failure; Humans; Jaundice, Obstructive; Liver Neoplasms; Lymphatic Metastasis; Male; Pancreatic Neoplasms; Stents; Survivors; Tegafur; Uracil | 2004 |
[A case of liver metastases of breast cancer successfully treated by combination chemotherapy using hepatic arterial infusion of docetaxel and systemic administration of trastuzumab].
Topics: Administration, Oral; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Combined Modality Therapy; Cyclophosphamide; Docetaxel; Drug Administration Schedule; Drug Combinations; Female; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Mastectomy, Segmental; Taxoids; Tegafur; Trastuzumab; Uracil | 2004 |
[A case of giant hepatocellular carcinoma treatable with radio frequent ablation therapy after effective UFT administration].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Catheter Ablation; Combined Modality Therapy; Humans; Liver Neoplasms; Male; Tegafur; Uracil | 2004 |
Oral administration of uracil-tegafur (UFT) inhibits liver micrometastasis of human colon cancer in an orthotopic nude mouse model and its early detection system.
Topics: Administration, Oral; Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Disease Models, Animal; Drug Therapy, Combination; Globins; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Polymerase Chain Reaction; Tegafur; Tumor Cells, Cultured; Uracil | 2004 |
[A case of successful management of nonresectable pancreas cancer with liver metastasis by intra-arterial infusion chemotherapy with gemcitabine hydrochloride, 5-FU, CDDP and administration of tegafur/uracil].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Drug Administration Schedule; Drug Combinations; Fluorouracil; Gemcitabine; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Male; Pancreatic Neoplasms; Quality of Life; Tegafur; Uracil | 2004 |
[Case report--Complete response of liver metastasis of rectal cancer after combination chemotherapy of CPT-11 + UFT-E].
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Drug Administration Schedule; Humans; Irinotecan; Liver Neoplasms; Male; Middle Aged; Rectal Neoplasms; Tegafur; Uracil | 2004 |
[The 5-fluorouracil hepato-arterial infusion with oral UFT therapy for the hepatic and extra hepatic metastases of colorectal cancer].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Administration Schedule; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Tegafur; Uracil | 2004 |
[A case report--Efficacy of combination therapy to unresectable advanced gall bladder carcinoma--palliative operation, hepatic arterial infusion therapy, and radiation therapy].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Combined Modality Therapy; Drug Combinations; Duodenal Neoplasms; Fluorouracil; Gallbladder Neoplasms; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Mitomycin; Palliative Care; Stents; Tegafur; Uracil | 2004 |
[A case of long-term survivor with multiple pulmonary metastases of HCC after hepatic resection].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Drug Combinations; Fluorouracil; Hepatectomy; Humans; Interferon-alpha; Interferon-beta; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Oxonic Acid; Pyridines; Tegafur; Time Factors; Uracil | 2004 |
[A case of liver metastases from cecal cancer successfully treated with fluorouracil and folinic acid (UFT/LV)].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cecal Neoplasms; Chemotherapy, Adjuvant; Colectomy; Drug Administration Schedule; Drug Combinations; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Male; Tegafur; Uracil | 2005 |
[Pharmacokinetic modulating chemotherapy for rectal carcinoma metastases to the liver and lung--a case report].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Administration Schedule; Drug Combinations; Female; Fluorouracil; Humans; Liver Neoplasms; Lung Neoplasms; Rectal Neoplasms; Tegafur; Uracil | 2005 |
[A case with advanced carcinoma of the gallbladder responding to UFT monotherapy].
Topics: Adenocarcinoma, Papillary; Administration, Oral; Aged; Antineoplastic Agents; Drug Combinations; Female; Gallbladder Neoplasms; Humans; Liver Neoplasms; Lung Neoplasms; Quality of Life; Tegafur; Uracil | 2005 |
[A case of anthracycline and taxane-resistant breast cancer with life-thereatening multiple liver metastases responding to oral combination chemotherapy by UFT, cyclophosphamide and medroxyprogesterone acetate].
Topics: Adenocarcinoma, Scirrhous; Administration, Oral; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Bridged-Ring Compounds; Cyclophosphamide; Drug Administration Schedule; Drug Combinations; Drug Resistance, Neoplasm; Female; Humans; Liver Neoplasms; Medroxyprogesterone Acetate; Middle Aged; Taxoids; Tegafur; Uracil | 2005 |
[Combined chemotherapy with oral leucovorin (LV) + tegafur/uracil (UFT) and hepatic arterial infusion (HAI) therapy for liver metastasis of colorectal cancer].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Administration Schedule; Drug Combinations; Female; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Leucovorin; Liver Neoplasms; Male; Middle Aged; Tegafur; Uracil | 2005 |
The MMP-9 expression determined the efficacy of postoperative adjuvant chemotherapy using oral fluoropyrimidines in stage II or III colorectal cancer.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Disease-Free Survival; Female; Floxuridine; Humans; Liver Neoplasms; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Postoperative Period; Retrospective Studies; Survival Rate; Tegafur; Uracil | 2006 |
Long-term survival after hepatectomy for hepatic recurrence of carcinoma of the papilla of Vater.
Topics: Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Aged; Ampulla of Vater; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Common Bile Duct Neoplasms; Hepatectomy; Humans; Liver Neoplasms; Male; Pancreaticoduodenectomy; Tegafur; Treatment Outcome; Uracil | 2005 |
[Case report--postoperative continuous intraarterial infusion of small doses of 5-FU successfully controlled residual tumor and liver metastasis of stage IV gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Doxorubicin; Drug Combinations; Floxuridine; Fluorouracil; Gastrectomy; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Methotrexate; Mitomycin; Neoplasm Staging; Picibanil; Proteoglycans; Stomach Neoplasms; Tegafur; Uracil | 2005 |
[A case of colon cancer with multiple liver, lung and bone metastases successfully treated with combined weekly high-dose 5-FU (WHF) chemotherapy with UFT and CPT-11].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Camptothecin; Colectomy; Colonic Neoplasms; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Female; Fluorouracil; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Irinotecan; Liver Neoplasms; Lung Neoplasms; Middle Aged; Tegafur; Uracil | 2005 |
[A case of multiple hepatic and peritoneal metastases from colon cancer responding to oral UFT+leucovorin chemotherapy].
Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Colectomy; Colonic Neoplasms; Combined Modality Therapy; Drug Administration Schedule; Female; Humans; Leucovorin; Liver Neoplasms; Middle Aged; Peritoneal Neoplasms; Quality of Life; Remission Induction; Tegafur; Uracil | 2005 |
[Hepatic arterial infusion (HAI) chemotherapy achieved a complete response (CR) for multiple liver metastases of colorectal cancer--two case reports].
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colorectal Neoplasms; Fluorouracil; Hepatectomy; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Remission Induction; Tegafur; Uracil | 2005 |
[A successful surgical treatment for solitary pulmonary and adrenal metastases after hepatic resection to hepatocellular carcinoma--a case report].
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Embolization, Therapeutic; Hepatectomy; Humans; Liver Neoplasms; Lung Neoplasms; Pneumonectomy; Tegafur; Treatment Outcome; Uracil | 2005 |
[A 6-year-survival case of esophageal adenosquamous cancer with liver metastases cured by multidisciplinary therapy].
Topics: Aged; Anastomosis, Surgical; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Esophageal Neoplasms; Esophagus; Gastric Fundus; Humans; Liver Neoplasms; Male; Proteoglycans; Quality of Life; Survivors; Tegafur; Uracil | 2006 |
[A case of hepatic metastases of sigmoid colon cancer which completely responded to systemic l-leucovorin/5-FU therapy and oral LV/UFT combination therapy].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Combinations; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Male; Sigmoid Neoplasms; Tegafur; Uracil | 2006 |
[Second-line chemotherapy with pharmacokinetic modulating chemotherapy for unresectable colorectal carcinoma recurrences resistant to 5-FU-based chemotherapy].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chronotherapy; Colonic Neoplasms; Drug Administration Schedule; Drug Combinations; Female; Fluorouracil; Humans; Infusions, Intravenous; Leucovorin; Liver Neoplasms; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Rectal Neoplasms; Survival Rate; Tegafur; Uracil | 2006 |
[Advanced rectal cancer in an older patient, in whom metastatic liver lesions were effectively controlled with oral UFT+LV and venous CPT-11 administration--case report].
Topics: Adenocarcinoma; Administration, Oral; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colon, Sigmoid; Colostomy; Drug Administration Schedule; Drug Combinations; Humans; Infusions, Intra-Arterial; Irinotecan; Leucovorin; Liver Neoplasms; Male; Omentum; Peritoneal Neoplasms; Rectal Neoplasms; Remission Induction; Tegafur; Uracil | 2006 |
[A case of recurrent pancreatic cancer responding to TS-1 combined gemcitabine chemotherapy after UFT combined gemcitabine chemotherapy resulting progressive disease].
Topics: Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Administration Schedule; Drug Combinations; Female; Gemcitabine; Humans; Jaundice, Obstructive; Liver Neoplasms; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Oxonic Acid; Pancreatic Neoplasms; Pyridines; Quality of Life; Remission Induction; Tegafur; Uracil | 2006 |
[A case of recurrent gastric cancer with dihydropyrimidine dehydrogenase (DPD) deficiency].
Topics: Adult; Anorexia; Antimetabolites, Antineoplastic; Bone Neoplasms; Cerebral Hemorrhage; Dihydropyrimidine Dehydrogenase Deficiency; Drug Combinations; Fatal Outcome; Humans; Liver Neoplasms; Male; Nausea; Oxonic Acid; Stomach Neoplasms; Tegafur; Uracil | 2006 |
[A patient with pancreatic cancer and multiple liver metastases after total pancreatectomy who showed a partial response to combination chemotherapy with gemcitabine and UFT].
Topics: Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; CA-19-9 Antigen; Combined Modality Therapy; Deoxycytidine; Drug Administration Schedule; Drug Combinations; Gemcitabine; Humans; Liver Neoplasms; Male; Pancreatectomy; Pancreatic Neoplasms; Quality of Life; Remission Induction; Tegafur; Uracil | 2006 |
[A case of effective multidisciplinary treatment with hepatic resection for synchronous multiple liver metastases from rectal cancer].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Doxorubicin; Drug Administration Schedule; Drug Combinations; Fluorouracil; Humans; Liver Neoplasms; Male; Middle Aged; Mitomycin; Quality of Life; Rectal Neoplasms; Remission Induction; Tegafur; Uracil | 2006 |
[Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma providing a good QOL].
Topics: Aged; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cisplatin; Epirubicin; Fluorouracil; Hepatectomy; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Quality of Life; Tegafur; Tomography, X-Ray Computed; Uracil | 2006 |
[A long survival case of sigmoid colon cancer patient with initially unresectable hepatic metastases].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Fluorouracil; Hepatectomy; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Middle Aged; Neoadjuvant Therapy; Second-Look Surgery; Sigmoid Neoplasms; Survivors; Tegafur; Uracil | 2007 |
[A case of liver metastasis of gastric cancer undergoing non-curative operation responding completely to combination therapy of S-1 and CDDP].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Drug Combinations; Gastrectomy; Humans; Liver Neoplasms; Male; Neoplasm Staging; Oxonic Acid; Quality of Life; Stomach Neoplasms; Tegafur; Uracil | 2007 |
[A case of unresectable colon cancer responding to oral leucovorin+oral tegafur/uracil].
Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Colon, Sigmoid; Combined Modality Therapy; Drug Administration Routes; Drug Combinations; Gastric Bypass; Hepatectomy; Humans; Jejunum; Leucovorin; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Palliative Care; Second-Look Surgery; Sigmoid Neoplasms; Tegafur; Uracil | 2007 |
Successful treatment with low-dose oral chemotherapy in a patient with metastatic hepatocellular carcinoma.
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Dose-Response Relationship, Drug; Humans; Liver Neoplasms; Male; Neoplasm Metastasis; Remission Induction; Tegafur; Uracil | 2007 |
[A case report--combination chemotherapy with oral UFT and CPT-11, 5-FU, l-LV by hepatic arterial infusion for multiple hepatic metastasis from sigmoid colon cancer].
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Female; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Irinotecan; Leucovorin; Liver Neoplasms; Middle Aged; Sigmoid Neoplasms; Tegafur; Uracil | 2007 |
[A case of complete remission(CR)persisting from UFT-E in an old patient with liver metastasis of gastric cancer].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Liver Neoplasms; Remission Induction; Stomach Neoplasms; Tegafur; Tomography Scanners, X-Ray Computed; Uracil | 2008 |
[Effective treatment with oral administration of UFT and leucovorin (Uzel) in a patient with liver metastasis and peritoneal dissemination from cecal cancer].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Cecal Neoplasms; Female; Humans; Leucovorin; Liver Neoplasms; Tegafur; Tomography, X-Ray Computed; Uracil | 2008 |
[Clinical experiences with UFD-1].
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Fluorouracil; Humans; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasms; Stomach Neoplasms; Tegafur; Uracil | 1982 |
Inhibitory effect of simultaneous intraportal administration of 5-fluorouracil, uracil and degradable starch microspheres on experimental hepatic micrometastasis, is of colon cancer.
Topics: Animals; Colorectal Neoplasms; Fluorouracil; Infusions, Intravenous; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Microspheres; Starch; Uracil | 1994 |
Postoperative prophylactic lipiodolization reduces the intrahepatic recurrence of hepatocellular carcinoma.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemotherapy, Adjuvant; Chemotherapy, Cancer, Regional Perfusion; Disease-Free Survival; Epirubicin; Feasibility Studies; Female; Fluorouracil; Hepatectomy; Humans; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Postoperative Care; Prospective Studies; Survival Rate; Tegafur; Uracil | 1995 |
[A case of gastric cancer with multiple liver metastasis responding to combined therapy with UFT and mitomycin C].
Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Gastrectomy; Humans; Infusions, Intravenous; Liver Neoplasms; Mitomycin; Stomach Neoplasms; Tegafur; Uracil | 1995 |
[A case of hepatocellular carcinoma with bone metastasis responding to oral administration of UFT].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Male; Middle Aged; Tegafur; Uracil | 1995 |
[A case of multiple liver metastasis from remnant gastric cancer responding to leucovorin.5-FU+UFT therapy].
Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Fluorouracil; Humans; Infusions, Intravenous; Leucovorin; Liver Neoplasms; Male; Neoplasm, Residual; Stomach Neoplasms; Tegafur; Uracil | 1995 |
[A case of huge liver metastasis from jejunal leiomyosarcoma completely controlled by intra-arterial and intra-portal vein infusion chemotherapy following hepatectomy].
Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Epirubicin; Female; Hepatectomy; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Infusions, Intravenous; Jejunal Neoplasms; Leiomyosarcoma; Liver Neoplasms; Portal Vein; Remission Induction; Tegafur; Uracil | 1994 |
[A case of small cell carcinoma of the stomach with multiple liver metastases].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cisplatin; Gastrectomy; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Neoplasm Invasiveness; Picibanil; Stomach Neoplasms; Tegafur; Uracil | 1994 |
[A case of hepatocellular carcinoma whose lung metastases and tumor emboli in the inferior vena cava disappeared by oral administration of UFT].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Humans; Liver Neoplasms; Lung Neoplasms; Male; Neoplastic Cells, Circulating; Tegafur; Uracil; Vena Cava, Inferior | 1994 |
[Portal-transfer of an orally administered anti-cancer agent analysis of the time course of portal blood and systemic blood levels of preoperatively administered UFT].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Administration Schedule; Female; Humans; Liver Neoplasms; Male; Middle Aged; Portal Vein; Tegafur; Uracil | 1994 |
[A comparative study on the serum and tissue 5-FU concentrations in patients with hepatocellular carcinoma after preoperative oral administration of UFT and 5'-DFUR].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemotherapy, Adjuvant; Drug Administration Schedule; Female; Floxuridine; Fluorouracil; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Tegafur; Uracil | 1994 |
[A case of advanced hepatocellular carcinoma, in which the tumor almost disappeared by orally administered UFT].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Male; Middle Aged; Tegafur; Uracil | 1993 |
[Vanishing tumor thrombus in IVC after oral administration of UFT and TAE in a patient with HCC; a case report].
Topics: Aged; Carcinoma, Hepatocellular; Combined Modality Therapy; Drug Combinations; Embolization, Therapeutic; Humans; Iodized Oil; Liver Neoplasms; Male; Neoplastic Cells, Circulating; Tegafur; Uracil; Vena Cava, Inferior | 1993 |
[A case of giant hepatocellular carcinoma effectively treated by UFT].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Biomarkers, Tumor; Carcinoma, Hepatocellular; Female; Humans; Liver Neoplasms; Protein Precursors; Prothrombin; Remission Induction; Tegafur; Uracil | 1993 |
[A case of hepatocellular carcinoma with portal invasion and right adrenal gland metastasis showing marked contraction of primary tumor and metastasis with treated by UFT alone].
Topics: Adrenal Gland Neoplasms; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Female; Humans; Liver Neoplasms; Neoplasm Invasiveness; Portal System; Tegafur; Uracil | 1994 |
Effect of 5-fluorouracil and UFT on experimental liver metastasis model of colorectal cancer using mouse colon 26 cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Drug Combinations; Drug Screening Assays, Antitumor; Fluorouracil; Liver Neoplasms; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Tegafur; Uracil | 1993 |
[The present status of chemotherapy for hepatocellular carcinoma].
Topics: Administration, Oral; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Doxorubicin; Drug Delivery Systems; Fluorouracil; Humans; Infusion Pumps; Infusions, Intra-Arterial; Liver Neoplasms; Mitomycin; Survival Rate; Tegafur; Uracil | 1993 |
[A case of gastric cancer with multiple liver metastases showing marked efficacy of preoperative and postoperative chemotherapy with CDDP, MMC and UFT(PMU), or CDDP, MMC, UFT and etoposide (PMUE)].
Topics: Adenocarcinoma, Papillary; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Etoposide; Hepatectomy; Hepatic Artery; Humans; Infusion Pumps; Liver Neoplasms; Lymphatic Metastasis; Male; Mitomycin; Postoperative Care; Preoperative Care; Stomach Neoplasms; Tegafur; Uracil | 1993 |
[A case of advance colon cancer responding to sequential methotrexate and 5-fluorouracil therapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Drug Administration Schedule; Female; Fluorouracil; Humans; Liver Neoplasms; Methotrexate; Middle Aged; Remission Induction; Tegafur; Uracil | 1993 |
[A case of advanced gastric cancer responding to chemotherapy and radiotherapy].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Ethanol; Fluorouracil; Gastrectomy; Humans; Injections, Intralesional; Liver Neoplasms; Male; Picibanil; Stomach Neoplasms; Tegafur; Uracil | 1996 |
[A case of hepatocellular carcinoma with reduction of primary tumor and disappearance of multiple lung metastasis].
Topics: Administration, Oral; Carcinoma, Hepatocellular; Drug Combinations; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Remission Induction; Tegafur; Uracil | 1996 |
[A case of hepatocellular carcinoma responding to oral administration of UFT].
Topics: Administration, Oral; Aged; alpha-Fetoproteins; Biomarkers; Carcinoma, Hepatocellular; Drug Combinations; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Protein Precursors; Prothrombin; Tegafur; Uracil | 1996 |
[A case of early gastric cancer transformed from adenoma by chemotherapy and radiotherapy].
Topics: Adenoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Liver Neoplasms; Lymphoma; Male; Neoplasms, Second Primary; Prednisolone; Stomach Neoplasms; Tegafur; Uracil; Vincristine | 1996 |
[Successful UFT-E granule and 5-FUCDDP combination therapy for an unresectable advanced gastric cancer complicated with liver metastasis].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Combinations; Gastrectomy; Humans; Liver Neoplasms; Male; Parenteral Nutrition, Home; Quality of Life; Stomach Neoplasms; Tegafur; Uracil | 1996 |
[A case of advanced gastric cancer with multiple liver metastasis successfully treated with combination chemotherapy using UFT, CDDP and etoposide].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Drug Combinations; Etoposide; Humans; Injections, Intravenous; Lentinan; Leukopenia; Liver Neoplasms; Male; Nausea; Stomach Neoplasms; Tegafur; Thrombocytopenia; Uracil | 1996 |
A case of advanced gastric cancer complicated by severe toxicity induced by a combination of tegafur, uracil and mitomycin C, and associated with abnormal pharmacokinetics.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Bone Marrow Diseases; Diarrhea; Dihydrouracil Dehydrogenase (NADP); Drug Combinations; Female; Humans; Liver Neoplasms; Lymphatic Metastasis; Middle Aged; Mitomycin; Oxidoreductases; Stomach Neoplasms; Tegafur; Uracil | 1996 |
[A case of advanced gastric cancer showing complete disappearance of cancer cells in multiple liver metastases due to low-dose PMUE therapy].
Topics: Adenocarcinoma, Papillary; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Etoposide; Gastrectomy; Humans; Liver Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Mitomycin; Stomach Neoplasms; Tegafur; Uracil | 1996 |
[Antimetastatic effects of UFT on murine liver metastasis model using L5178YHM lymphoma].
Topics: Animals; Body Weight; Drug Combinations; Floxuridine; Leukemia L5178; Liver Neoplasms; Male; Mice; Tegafur; Uracil | 1996 |
[A case of hepatocellular carcinoma with reduction of primary tumor and disappearance of multiple lung metastasis].
Topics: Administration, Oral; alpha-Fetoproteins; Antineoplastic Agents; Biomarkers, Tumor; Carcinoma, Hepatocellular; Drug Administration Schedule; Drug Combinations; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Tegafur; Uracil | 1998 |
[Complete disappearance of metastatic pulmonary tumors in a case of hepatocellular carcinoma treated with UFT].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Drug Combinations; Female; Humans; Liver Neoplasms; Lung Neoplasms; Remission Induction; Tegafur; Uracil | 1998 |
[A case of giant hepatocellular carcinoma effectively treated with UFT].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Drug Combinations; Humans; Liver Neoplasms; Male; Remission Induction; Tegafur; Uracil | 1998 |
[Complete remission of liver metastasis from rectal cancer following continuous oral administration of tegafur-uracil after intrahepatic arterial single injection of CDDP and 5-FU].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Fluorouracil; Hepatic Artery; Humans; Injections, Intra-Arterial; Liver Neoplasms; Male; Rectal Neoplasms; Remission Induction; Tegafur; Uracil | 1998 |
Effects of systemic and regional chemotherapy after hepatic resection for colorectal metastases.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Female; Humans; Injections, Intralesional; Injections, Intravenous; Liver Neoplasms; Male; Medical Records; Middle Aged; Mitomycin; Multivariate Analysis; Retrospective Studies; Tegafur; Uracil | 1998 |
Complete remission of multiple hepatocellular carcinomas associated with hepatitis C virus-related, decompensated liver cirrhosis by oral administration of enteric-coated tegafur/uracil.
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Female; Hepatitis C; Humans; Liver Cirrhosis; Liver Neoplasms; Neoplasms, Multiple Primary; Remission Induction; Tablets, Enteric-Coated; Tegafur; Tomography, X-Ray Computed; Uracil | 1999 |
[Effective chemo-endocrine combination therapy for obstructive-jaundice caused by multiple liver metastasis of recurrent breast cancer--a case report].
Topics: Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cholestasis; Cyclophosphamide; Doxorubicin; Drainage; Female; Floxuridine; Fluorouracil; Humans; Liver Neoplasms; Lung Neoplasms; Mastectomy, Radical; Medroxyprogesterone Acetate; Tamoxifen; Tegafur; Toremifene; Uracil | 1999 |
[A case of advanced gastric cancer (type 3) with pyloric stenosis, multiple liver and lymph node metastases responding to UFT-E granules and lentinan].
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Humans; Lentinan; Liver Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Pyloric Stenosis; Stomach Neoplasms; Tegafur; Uracil | 2000 |
[A case of advanced gastric cancer with hepatic metastasis successfully treated by combined chemotherapy with UFT and lentinan].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Gastrectomy; Humans; Lentinan; Liver Neoplasms; Lymphatic Metastasis; Male; Stomach Neoplasms; Tegafur; Uracil | 2000 |
[A case of advanced hepatocellular carcinoma with lung and bone metastases effectively treated by orally administered UFT].
Topics: Administration, Oral; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bone Neoplasms; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Protein Precursors; Prothrombin; Tegafur; Uracil | 2000 |
Complete disappearance of recurrent hepatocellular carcinoma with peritoneal dissemination and splenic metastasis: a unique clinical course after surgery.
Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Hepatocellular; Chemotherapy, Adjuvant; Drug Therapy, Combination; Female; Hepatectomy; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Peritoneal Neoplasms; Remission Induction; Splenic Neoplasms; Tegafur; Tomography, X-Ray Computed; Uracil | 2000 |
[A case of advanced rectal cancer with unresectable liver metastasis for which chemotherapy was markedly effective].
Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Fluorouracil; Humans; Infusion Pumps, Implantable; Liver Neoplasms; Middle Aged; Mitomycin; Rectal Neoplasms; Remission Induction; Tegafur; Uracil | 2000 |
[A case report of unresectable colon cancer that disappeared following pharmacokinetic modulation chemotherapy (PMC)].
Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Drug Administration Schedule; Fluorouracil; Humans; Infusions, Intravenous; Liver Neoplasms; Male; Peritoneal Neoplasms; Prognosis; Quality of Life; Remission Induction; Tegafur; Uracil | 2000 |
[A successful case of preoperative intermittent hepatic arterial infusion of high-dose 5-FU and pharmacokinetic modulating chemotherapy against unresectable liver metastasis of colon cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Administration Schedule; Fluorouracil; Hepatectomy; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Sigmoid Neoplasms; Tegafur; Uracil | 2000 |
[A case of breast cancer with multiple metastases successfully treated by medroxyprogesterone acetate with intermittent intra-arterial infusion low-dose chemotherapy to hepatic metastasis].
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Drug Administration Schedule; Female; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Recurrence, Local; Pleural Neoplasms; Tamoxifen; Tegafur; Uracil | 2000 |
[Three cases of liver metastasis of colon cancer responding to systemic combination chemotherapy utilizing CPT-11].
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Colonic Neoplasms; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Irinotecan; Liver Neoplasms; Male; Tegafur; Uracil | 2000 |
[Outcomes of home anti-cancer chemotherapy--estimation of hepatic arterial infusion chemotherapy for patients with multiple liver metastases].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colonic Neoplasms; Fluorouracil; Hepatic Artery; Home Care Services; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Quality of Life; Stomach Neoplasms; Survival Rate; Tegafur; Treatment Outcome; Uracil | 2000 |
Advanced hepatocellular carcinoma with distant metastases, successfully treated by a combination therapy of alpha-interferon and oral tegafur/uracil.
Topics: Administration, Oral; Adult; Angiography; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Humans; Interferon-alpha; Liver Neoplasms; Magnetic Resonance Imaging; Male; Tegafur; Tomography, X-Ray Computed; Uracil | 2000 |
[Long survival in a case of unresectable hepatic metastasis from rectal carcinoma treated with second-look hepatectomy plus pharmacokinetic modulating chemotherapy (PMC)].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Administration Schedule; Female; Fluorouracil; Hepatectomy; Hepatic Artery; Humans; Infusion Pumps; Infusions, Intra-Arterial; Liver Neoplasms; Mitomycin; Rectal Neoplasms; Reoperation; Tegafur; Uracil | 2001 |
[A case of gastric cancer with liver metastases successfully treated with combination therapy of systemic and hepatic arterial infusion chemotherapy].
Topics: Administration, Oral; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drug Combinations; Fluorouracil; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Liver Neoplasms; Male; Mitomycin; Stomach Neoplasms; Tegafur; Uracil | 2001 |
[Complete response of a massive hepatocellular carcinoma with lung metastasis to UFT (DPD inhibitory fluoroprymidines: DIF)].
Topics: Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Drug Combinations; Humans; Liver Neoplasms; Lung Neoplasms; Male; Tegafur; Uracil | 2001 |
[A case of advanced gastric cancer complicated with liver metastases responding remarkably to combined chemotherapy with 5-fluorouracil and low-dose cisplatin, with UFT and low-dose cisplatin for maintenance on an outpatient basis].
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Fluorouracil; Humans; Liver Neoplasms; Male; Stomach Neoplasms; Tegafur; Uracil | 2001 |
[A case of successful management of nonresectable pancreas cancer with liver metastasis by intra-arterial infusion chemotherapy with angiotensin-II and administration of tegafur/uracil].
Topics: Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Male; Methotrexate; Middle Aged; Pancreatic Neoplasms; Tegafur; Uracil | 2001 |
[Relationship between the anti-metastatic effect of UFT and in vitro chemosensitivity to 5-FU in metastatic tumors from orthotopic implanted colon cancer in nude rats].
Topics: Animals; Antineoplastic Agents; Colonic Neoplasms; Drug Combinations; Drug Screening Assays, Antitumor; Fluorouracil; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Neoplasm Transplantation; Rats; Rats, Nude; Tegafur; Transplantation, Heterologous; Uracil | 2001 |
Extraction of 5-fluorouracil by tumor and liver: a noninvasive positron emission tomography study of patients with gastrointestinal cancer.
Topics: Antimetabolites, Antineoplastic; Dihydrouracil Dehydrogenase (NADP); Enzyme Inhibitors; Fluorine Radioisotopes; Fluorouracil; Gastrointestinal Neoplasms; Humans; Liver; Liver Neoplasms; Models, Biological; Oxidoreductases; Pancreatic Neoplasms; Tomography, Emission-Computed; Uracil | 2001 |
[A case of advanced gastric cancer with multiple liver metastases in an elderly patient that responded dramatically to UFT therapy].
Topics: Adenocarcinoma; Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Agents; Combined Modality Therapy; Drug Administration Schedule; Drug Combinations; Female; Gastrectomy; Humans; Liver Neoplasms; Stomach Neoplasms; Tegafur; Uracil | 2001 |
[A case of breast cancer with multiple metastases effectively treated with long-term administration of docetaxel, aclarubicin and UFT].
Topics: Aclarubicin; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Docetaxel; Drug Administration Schedule; Drug Combinations; Female; Humans; Liver Neoplasms; Lung Neoplasms; Middle Aged; Paclitaxel; Taxoids; Tegafur; Uracil | 2001 |
[A case of spindle cell type hepatocellular carcinoma responding to hepatic intra-arterial infusion chemotherapy].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Drug Administration Schedule; Drug Combinations; Female; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Middle Aged; Tegafur; Uracil | 2002 |
[A case of complete response (CR) persisting for 2 years and 10 months from UFT-E in a patient with liver metastasis of gastric cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Drug Combinations; Fluorouracil; Gastrectomy; Humans; Leucovorin; Liver Neoplasms; Lymph Node Excision; Male; Methotrexate; Middle Aged; Remission Induction; Stomach Neoplasms; Tegafur; Uracil | 2002 |
[A case of liver metastasis of rectal cancer demonstrating complete response to 5-FU + Leucovorin + UFT].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Combinations; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Male; Middle Aged; Rectal Neoplasms; Remission Induction; Tegafur; Uracil | 2002 |
[A case of rectal cancer with multiple liver metastases that responded dramatically to pharmacokinetic modulating chemotherapy/CPT-11 therapy].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Infusions, Intravenous; Irinotecan; Liver Neoplasms; Male; Rectal Neoplasms; Tegafur; Uracil | 2002 |
Purine and pyrimidine transport by cultured Novikoff cells. Specificities and mechanism of transport and relationship to phosphoribosylation.
Topics: Adenine; Animals; Biological Transport, Active; Calorimetry; Carcinoma, Hepatocellular; Cell Line; Centrifugation, Density Gradient; Chloromercuribenzoates; Cytochalasin B; Cytosine; Dipyridamole; Dithiothreitol; Guanine; Hypoxanthine Phosphoribosyltransferase; Hypoxanthines; Kinetics; Liver Neoplasms; Neoplasms, Experimental; Pentosyltransferases; Purines; Pyrimidines; Rats; Thermodynamics; Time Factors; Uracil | 1975 |
Uptake in vitro of nucleic acid precursors and nucleic acids by Zajdela ascitic hepatoma cells.
Topics: Adenine; Animals; Biological Transport, Active; Carcinoma, Hepatocellular; Cell Line; DNA; DNA, Bacterial; Liver; Liver Neoplasms; Orotic Acid; Rats; Ribonucleosides; RNA; RNA, Bacterial; Uracil; Uridine | 1975 |
The reduction of uridine 5'-diphosphate and uridine 5'-triphosphate in some transplantable rat hepatomas.
Topics: Animals; Carcinoma, Hepatocellular; Deoxyribonucleosides; Deoxyribonucleotides; Hydrolysis; Hydroxyurea; Liver; Liver Neoplasms; Male; Neoplasms, Experimental; Oxidation-Reduction; Rats; Ribonucleotide Reductases; Uracil; Uracil Nucleotides; Uridine; Uridine Diphosphate Glucose; Uridine Monophosphate | 1977 |
Radioactive nucleic acids-precursors: their potential value as tumor-localizing agents.
Topics: Animals; Carcinoma, Hepatocellular; Deoxyuridine; DNA; Iodine Radioisotopes; Leukemia, Lymphoid; Liver Neoplasms; Lymphoma, Non-Hodgkin; Mice; Mice, Inbred AKR; Mice, Inbred C3H; Neoplasm Transplantation; Neoplasms; Neoplasms, Experimental; Nucleic Acid Precursors; Radionuclide Imaging; Rats; RNA; Uracil | 1977 |
Incorporation characteristics of uracil, uridine, and orotic acid into ribonucleic acid of neoplastic cells.
Topics: Adult; Aged; Animals; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Female; Humans; Liver; Liver Neoplasms; Male; Mice; Middle Aged; Orotic Acid; RNA, Neoplasm; Sarcoma, Experimental; Stomach Neoplasms; Uracil; Uridine; Uridine Kinase; Uridine Phosphorylase | 1977 |
Uridine transport in Novikoff rat hepatoma cells and other cell lines and its relationship to uridine phosphorylation and phosphorolysis.
Topics: Adenosine Triphosphate; Animals; Carcinoma, Hepatocellular; Cell Line; Chloromercuribenzoates; Liver Neoplasms; Neoplasms, Experimental; Nucleosides; Phosphorylation; Rats; Uracil; Uridine; Uridine Kinase | 1978 |
[Sharp decline in plasma CEA and reduction of liver metastasis after UFT administration in a patient with recurrent gastric cancer].
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoembryonic Antigen; Gastrectomy; Gastroscopy; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Stomach Neoplasms; Tegafur; Uracil | 1992 |
[PMUE therapy (CDDP, MMC, UFT, etoposide) for advanced gastric cancer--a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Etoposide; Gastrectomy; Humans; Liver Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Remission Induction; Reoperation; Stomach Neoplasms; Tegafur; Uracil | 1992 |
[A case of gastric cancer with multiple liver metastases effectively treated with PMUE (CDDP, MMC, UFT, etoposide) hepatic arterial chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Etoposide; Gastrectomy; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Prognosis; Stomach Neoplasms; Tegafur; Uracil | 1992 |
[Effects of UFT and loxiglumide (CR1505) on liver metastasis of human pancreatic cancer cell line, KP-1 N in nude mice].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Cholecystokinin; Humans; Liver Neoplasms; Mice; Mice, Nude; Pancreatic Neoplasms; Proglumide; Tegafur; Tumor Cells, Cultured; Uracil | 1992 |
[A case of advanced gastric cancer with liver metastasis completely responding to a combined immunochemotherapy with UFT, mitomycin C and lentinan].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Humans; Lentinan; Liver Neoplasms; Male; Mitomycin; Remission Induction; Stomach Neoplasms; Tegafur; Uracil | 1992 |
[A resected case of advanced gastric cancer with complete remission of liver metastasis by chronic daily administration of oral etoposide and UFT].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Etoposide; Gastrectomy; Humans; Liver Neoplasms; Lymph Node Excision; Male; Mitomycin; Remission Induction; Stomach Neoplasms; Tegafur; Uracil | 1992 |
[Rupture of hepatocellular carcinoma with multiple pulmonary metastasis successfully treated by transcatheter arterial embolization (TAE) of tumor: a case report].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Doxorubicin; Female; Hepatic Artery; Humans; Iodized Oil; Liver Neoplasms; Lung Neoplasms; Mitomycin; Picibanil; Prognosis; Remission Induction; Rupture, Spontaneous; Tegafur; Uracil | 1991 |
[Antitumor activity of T-506, a novel synthetic FUDR derivative, on murine colon cancer and its hepatic metastasis].
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Floxuridine; Fluorodeoxyuridylate; Liver Neoplasms; Mice; Mice, Inbred BALB C; Tegafur; Uracil | 1991 |
[Regional immunochemotherapy for liver metastasis of esophageal cancer in a patient with variant hepatic artery].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Esophageal Neoplasms; Fluorouracil; Hepatic Artery; Humans; Infusion Pumps; Infusions, Intra-Arterial; Injections, Intramuscular; Liver Neoplasms; Male; Middle Aged; Picibanil; Tegafur; Uracil | 1991 |
[Effect of UFT by oral administration using a murine hepatic metastasis model].
Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Humans; Interleukin-1; Interleukin-2; Killer Cells, Lymphokine-Activated; Killer Cells, Natural; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Tegafur; Uracil | 1991 |
[Clinical experiences with hyperthermochemotherapy of hepatic metastasis from gastric cancer].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Female; Gastrectomy; Humans; Hyperthermia, Induced; Injections, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Prognosis; Stomach Neoplasms; Tegafur; Uracil | 1991 |
[CDDP-ip PMUE therapy in gastric cancer cases with liver metastasis].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Gastrectomy; Humans; Infusions, Parenteral; Injections, Intravenous; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Mitomycins; Peritonitis; Stomach Neoplasms; Tegafur; Uracil | 1991 |
Primary adenocarcinoma of duodenal bulb benefitted by chemotherapy.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Duodenal Neoplasms; Humans; Liver Neoplasms; Male; Middle Aged; Mitomycins; Tegafur; Uracil | 1991 |
[Tissue UFT distribution and histological changes following UFT administration in metastatic liver cancer cases].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Female; Fluorouracil; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Tegafur; Uracil | 1990 |
[Results of prophylactic intra-arterial infusion chemotherapy after hepatic resection in colorectal metastases].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Fluorouracil; Hepatectomy; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Mitomycin; Mitomycins; Neoplasm Recurrence, Local; Postoperative Care; Tegafur; Uracil | 1990 |
The effect of UFTM therapy on primary and metastatic colon cancer from the same human xenotransplanted into nude mice.
Topics: Adenocarcinoma, Mucinous; Animals; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Colonic Neoplasms; Drug Administration Schedule; Female; Humans; Liver Neoplasms; Lymphatic Metastasis; Mice; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Mitomycins; Neoplasm Transplantation; Tegafur; Uracil | 1990 |
[Therapy of hepatocellular carcinoma with UFT--clinical evaluation of its effect in the combination therapy with transcatheter arterial embolization or one shot therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Combined Modality Therapy; Drug Evaluation; Embolization, Therapeutic; Female; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Prognosis; Survival Rate; Tegafur; Uracil | 1990 |
[A case of biliary tract obstruction due to metastatic hepatic cancer, in which topical injection of CDDP and ADM into PTCD with concomitant use of UFT resulting in partial reopening of biliary tract].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bile Ducts, Intrahepatic; Catheters, Indwelling; Cholestasis; Cisplatin; Combined Modality Therapy; Doxorubicin; Drainage; Humans; Injections; Liver Neoplasms; Male; Middle Aged; Stomach Neoplasms; Tegafur; Uracil | 1989 |
[Study on the pharmacokinetics of UFT in patients with hepatocellular carcinoma associated with cirrhosis].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Female; Fluorouracil; Humans; Liver; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Tegafur; Thymidylate Synthase; Uracil | 1989 |
[Almost complete disappearance of metastatic pulmonary tumor and reduction of the main hepatic mass in a case of hepatocellular carcinoma treated with UFT].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Female; Humans; Liver Neoplasms; Lung; Lung Neoplasms; Middle Aged; Tegafur; Tomography, X-Ray Computed; Uracil | 1987 |
[A case of hepatocellular carcinoma with extrahepatic portal vein obstruction due to tumor invasion, responsive to oral administration of UFT].
Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Male; Neoplasm Invasiveness; Portal Vein; Tegafur; Thrombosis; Uracil | 1987 |
[5-Fluorouracil, tegafur, and uracil concentrations in serum and tissue of the patients with hepatocellular carcinoma after UFT administration].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Drug Combinations; Fluorouracil; Humans; Liver Neoplasms; Tegafur; Uracil | 1987 |
[Effects and side effects of long-term administration of oral antitumor agents in patients with hepatocellular carcinoma--especially, relation to aggravation of liver function].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Combined Modality Therapy; Embolization, Therapeutic; Female; Humans; Liver; Liver Function Tests; Liver Neoplasms; Male; Middle Aged; Tegafur; Uracil | 1987 |
[Anticancer effect of UFT in intrahepatic recurrence with tumor embolus in the left portal vein after hepatectomy of hepatoma--a case report].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Hepatectomy; Humans; Liver Neoplasms; Male; Portal Vein; Postoperative Complications; Tegafur; Thrombosis; Uracil | 1988 |
[Risk factors for side effects of long-term administration of 5-fluorouracil derivatives in patients with hepatocellular carcinoma associated with liver cirrhosis--relationship with serum concentration of anti-tumor agents and side effect].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Ascites; Brain Diseases; Carcinoma, Hepatocellular; Female; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Risk Factors; Tegafur; Time Factors; Uracil | 1988 |
Uridine phosphorylase from Novikoff rat hepatoma cells: purification, kinetic properties, and its role in uracil anabolism.
Topics: Animals; Carcinoma, Hepatocellular; Cell Division; Cell Line; Cricetinae; Humans; Inosine; Kinetics; Liver Neoplasms; Mice; Pentosyltransferases; Rats; Rats, Inbred Strains; Ribosemonophosphates; Uracil; Uridine Phosphorylase | 1985 |
Phase II study of co-administration of uracil and tegafur (UFT) in hepatocellular carcinoma. Tokyo Liver Cancer Chemotherapy Study Group.
Topics: Administration, Oral; Aged; Carcinoma, Hepatocellular; Drug Combinations; Female; Humans; Liver Neoplasms; Male; Middle Aged; Tegafur; Time Factors; Uracil | 1985 |
[Maintenance chemotherapy by UFT after trans-arterial embolization for hepatocellular carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Combined Modality Therapy; Embolization, Therapeutic; Humans; Iodized Oil; Liver Neoplasms; Tegafur; Uracil | 1986 |
[An unresectable case of hepatoma completely disappearing after oral administration of an anticancer drug (UFT)].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Male; Tegafur; Uracil | 1986 |
[A case of hepatocellular carcinoma with bone metastasis which responded to oral administration of UFT].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Male; Middle Aged; Tegafur; Tomography, X-Ray Computed; Uracil | 1987 |
[Clinical evaluation of MMC-mc-chemoembolization therapy and its combination with UFT in hepatocellular carcinoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Drug Administration Schedule; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Retrospective Studies; Tegafur; Uracil | 1987 |
[FT, 5-FU and uracil concentrations of the blood, bile and tissue of hepatoma with liver cirrhosis after oral administration of UFT].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Bile; Carcinoma, Hepatocellular; Female; Fluorouracil; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Tegafur; Uracil | 1987 |
[Effects of preoperative administration of UFT in gastrointestinal cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Female; Humans; Kinetics; Liver Neoplasms; Male; Middle Aged; Preoperative Care; Rectal Neoplasms; Stomach Neoplasms; Tegafur; Uracil | 1986 |
[Effects of oral administration of UFT in unresectable gastric cancer with liver metastasis].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Humans; Liver Neoplasms; Male; Middle Aged; Stomach Neoplasms; Tegafur; Uracil | 1986 |
[A case of relapsed gastric cancer treated successfully by chemotherapy--lung metastasis and relapsed cancer in the hepatic portal system].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carbazilquinone; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Picibanil; Portal System; Stomach Neoplasms; Tegafur; Uracil | 1986 |
[Changes in CT findings in patients with liver metastases of breast cancer during effective intra-arterial infusion].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Doxorubicin; Humans; Infusion Pumps; Infusions, Intra-Arterial; Liver; Liver Neoplasms; Mastectomy; Mitomycin; Mitomycins; Postoperative Period; Tegafur; Tomography, X-Ray Computed; Uracil | 1988 |
[Effects of UFT on experimental liver metastases and on the immunologic capacity of the hosts].
Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Female; Immune Tolerance; Immunity, Cellular; Liver Neoplasms; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Tegafur; Uracil | 1988 |
Improved high-performance liquid chromatographic assay for the quantification of 5-bromo-2'-deoxyuridine and 5-bromouracil in plasma.
Topics: Aged; Bromodeoxyuridine; Bromouracil; Chromatography, High Pressure Liquid; Colonic Neoplasms; Humans; Indicators and Reagents; Infusions, Intravenous; Liver Neoplasms; Male; Uracil | 1988 |
[Intra-arterial infusion chemotherapy using a subcutaneously implanted silicone reservoir--with reference to the chemotherapy protocol].
Topics: Abdominal Neoplasms; Aged; Antineoplastic Combined Chemotherapy Protocols; Catheterization; Cytarabine; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Silicone Elastomers; Stomach Neoplasms; Tegafur; Uracil | 1985 |
[A combined chemotherapy with UFT and mitomycin C in advanced gastric cancer; report of 2 cases].
Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Female; Humans; Injections, Intravenous; Liver Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Stomach Neoplasms; Tegafur; Uracil | 1985 |
Effect of ultraviolet light on mengovirus: formation of uracil dimers, instability and degradation of capsid, and covalent linkage of protein to viral RNA.
Topics: Animals; Carbon Radioisotopes; Carcinoma, Hepatocellular; Cell Line; Centrifugation, Density Gradient; Hemagglutination Tests; Liver Neoplasms; Mengovirus; Microscopy, Electron; Nucleoproteins; Phosphotungstic Acid; Protein Binding; Radiation Effects; Rats; RNA, Viral; Staining and Labeling; Time Factors; Tritium; Ultraviolet Rays; Uracil; Viral Proteins | 1974 |
Post-transcriptional inhibition of protein synthesis by rifampicin in rat hepatoma cells.
Topics: Ammonium Sulfate; Animals; Carbon Isotopes; Carcinoma, Hepatocellular; Cell Line; Cell Nucleus; DNA-Directed RNA Polymerases; Enzyme Activation; Enzyme Induction; Hydrocortisone; Leucine; Liver Neoplasms; Magnesium; Manganese; Neoplasm Proteins; Protein Biosynthesis; Rats; Rifampin; RNA, Neoplasm; Transcription, Genetic; Tyrosine Transaminase; Uracil | 1973 |
Differential sensitivity of rat liver and rat hepatoma cells to alpha-amanitin.
Topics: Adrenalectomy; Animals; Basidiomycota; Carbon Radioisotopes; Carcinoma, Hepatocellular; Cell Nucleus; Dactinomycin; DNA-Directed RNA Polymerases; Enzyme Induction; Hydrocortisone; Liver; Liver Neoplasms; Mycotoxins; Nucleotides; Oligopeptides; Orotic Acid; Peptides, Cyclic; Rats; Tritium; Tyrosine Transaminase; Uracil; Uridine | 1973 |
Activities of DNA nucleotidyltransferases and other enzymes in cell-free preparations from hepatomas of different growth rates.
Topics: Adenine Nucleotides; Animals; Carbon Isotopes; Carcinoma, Hepatocellular; Clinical Enzyme Tests; Cytosine Nucleotides; DNA, Neoplasm; Guanine Nucleotides; Hypoxanthines; Liver; Liver Neoplasms; Neoplasms, Experimental; Nucleosides; Nucleotides; Nucleotidyltransferases; Phosphotransferases; Rats; Thymidine; Uracil; Uridine | 1966 |
[Feedback-regulation of aspartate-transcarbamylase of various tissues].
Topics: Adenosine Triphosphate; Animals; Carcinoma 256, Walker; Carcinoma, Hepatocellular; Cytosine Nucleotides; Feedback; Female; Liver; Liver Neoplasms; Neoplasm Transplantation; Neoplasms, Experimental; p-Dimethylaminoazobenzene; Rats; Transferases; Uracil; Uracil Nucleotides | 1966 |
[Determination of 4-methyluracil in the serum of normal and tumorous rats].
Topics: Animals; Carcinoma 256, Walker; Carcinoma, Hepatocellular; Chromatography, Paper; Injections, Intraperitoneal; Liver Neoplasms; Neoplasms, Experimental; Rats; Spectrophotometry; Uracil | 1967 |
Nucleotide pools of Novikoff rat hepatoma cells growing in suspension culture. I. Kinetics of incorporation of nucleosides into nucleotide pools and pool sizes during growth cycle.
Topics: Animals; Aspartic Acid; Biological Transport; Carbon Isotopes; Carcinoma, Hepatocellular; Cell Line; Chromatography, Paper; Culture Media; Culture Techniques; Diffusion; DNA; Electrophoresis; Hypoxanthines; Kinetics; Liver Neoplasms; Neoplasms, Experimental; Nucleosides; Nucleotides; Orotic Acid; Rats; RNA; Thymidine; Time Factors; Tritium; Uracil; Uridine | 1971 |
Enzyme patterns in a group of transplantable mouse hepatomas of different growth rates.
Topics: Animals; Carboxy-Lyases; Carcinoma, Hepatocellular; Growth; Humans; Inbreeding; Liver; Liver Neoplasms; Lyases; Male; Methylcholanthrene; Mice; Neoplasm Transplantation; Ornithine Carbamoyltransferase; Oxidoreductases; Phosphotransferases; Pyrimidines; Thymidine Kinase; Transaminases; Transferases; Tryptophan Oxygenase; Uracil | 1971 |
[Experimental findings concerning the antineoplastic drug fluordopan].
Topics: Adenocarcinoma; Animals; Carcinoma 256, Walker; Carcinoma, Hepatocellular; Liver Neoplasms; Lymphoma, Non-Hodgkin; Melanoma; Neoplasms, Experimental; Nitrogen Mustard Compounds; Rats; Uracil | 1971 |
MOdified nucleosides of nuclear and nucleolar low molecular weight ribonucleic acid.
Topics: Adenine; Animals; Carcinoma, Hepatocellular; Cell Nucleolus; Cell Nucleus; Chromatography, Gel; Chromatography, Thin Layer; Cytosine; Electrophoresis, Polyacrylamide Gel; Glycols; Guanine; Hypoxanthines; Liver Neoplasms; Male; Molecular Weight; Neoplasms, Experimental; Nucleosides; Rats; RNA, Neoplasm; Thymine; Uracil | 1972 |
Inhibition of ribosomal ribonucleic acid maturation in Novikoff hepatoma cells by 5-fluorouracil and 5-fluorouridine.
Topics: Animals; Carbon Isotopes; Carcinoma, Hepatocellular; Cell Line; Electrophoresis; Fluorine; Fluorouracil; Kinetics; Liver Neoplasms; Methionine; Methylation; Neoplasms, Experimental; Rats; RNA, Ribosomal; Tritium; Uracil; Uridine | 1973 |
1-Nitroso-5, 6-dihydrouracil: induction of liver cell carcinomas and kidney adenomas in the rat.
Topics: Adenoma; Animals; Carcinoma, Hepatocellular; Female; Kidney Neoplasms; Lethal Dose 50; Liver Neoplasms; Male; Neoplasms, Experimental; Nitroso Compounds; Rats; Uracil | 1973 |
Incorporation of precursors and inhibitors of nucleic acid synthesis into hepatomas and liver of the rat.
Topics: Amino Acids; Animals; Carbon Radioisotopes; Carcinoma, Hepatocellular; Cell Line; Fluorouracil; Injections, Intraperitoneal; Injections, Subcutaneous; Liver; Liver Neoplasms; Liver Regeneration; Male; Neoplasm Transplantation; Neoplasms, Experimental; Orotic Acid; Phosphates; Rats; RNA, Neoplasm; Schistosomicides; Thioxanthenes; Thymidine; Time Factors; Transplantation, Homologous; Tritium; Uracil; Uridine | 1974 |
Dihydrouracil dehydrogenase activity in normal, differentiating and regnerating liver and in hepatomas.
Topics: Animals; Carcinoma, Hepatocellular; Cell Count; Cell Division; Female; Liver; Liver Neoplasms; Liver Regeneration; Male; NADP; Neoplasm Transplantation; Neoplasms, Experimental; Oxidoreductases; Rats; Spectrophotometry; Thymine; Transplantation, Homologous; Uracil | 1971 |
[Long-term intra-arterial infusion in the chemotherapy of cancer of the liver (preliminary communication)].
Topics: Adult; Catheterization; Celiac Artery; Female; Humans; Injections, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Uracil | 1973 |
A new method for treatment of carcinoma of the breast and colon with 5-fluorouracil.
Topics: Adult; Aged; Breast Neoplasms; Chemical Phenomena; Chemistry; Colonic Neoplasms; Female; Fluorouracil; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Thymine; Uracil | 1970 |